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Postoperative delirium (POD) is a public health and research priority (American Society 
of Anesthesiologists, 2019). POD is a risk factor for long-term neurocognitive decline, and the 
rate of decline is directly proportional to the severity of POD (Vasunilashorn et al., 2018). 
Baseline cognitive function is a strong, independent predictor for POD (Culley et al., 2017). The 
International Perioperative Neurotoxicity Working Group recommends baseline cognitive 
function be assessed for older patients prior to surgery and anesthesia (Berger, et al., 2018). 
Perioperative cognitive screening tools trialed in anesthesia are not routinely incorporated into 
clinical practice related to validity, reliability, or practicality problems (Berger, et al., 2018). The 
ideal perioperative cognitive screening tool would be rapid, easily-administrable, valid, reliable, 
automatically scored, void of language, cultural, and education bias and cost-efficient (Axley & 
Schenning, 2015). No such tool has been identified to date. This study, guided by Donabedian’s 
theoretical model, evaluated the utility of a novel point-of-care (POC) electroencephalography 
 
 
(EEG) system, WAVi MedicalTM (Boulder, CO),  for the perioperative neurocognitive 
assessment of older surgical patients. This study conducted a secondary analysis of data from the 
“Perioperative Brain Health” – IRB HM20019839 study. The “Perioperative Brain Health” study 
is an ongoing study collecting both pre- and postoperative questionnaire-based neurocognitive 
assessments alongside WAVi-derived P300 auditory evoked potentials. Data was analyzed using 
regression and analysis of variance. The WAVi MedicalTM system may one day offer anesthesia 
providers a novel neurocognitive assessment tool for predicting, identifying, and tracking 
perioperative neurocognitive disorders in older surgical patients. 
 
Keywords: perioperative neurocognitive disorders, postoperative delirium, older surgical 



















Chapter 1: Introduction 
Study and Chapter Overview 
 The purpose of this study was to explore baseline and postoperative neurocognitive 
characteristics that may help to establish novel predictive and trend metrics for perioperative 
neurocognitive assessment in older surgical patients. This study is important because 
neurobiomarkers obtainable with a new point-of-care (POC) electroencephalography (EEG) 
brain assessment device, WAVi MedicalTM (Boulder, CO), might provide anesthesia providers 
with a more detailed perioperative assessment of a patient’s brain, the primary target of 
anesthesia, than is currently available with questionnaire-based assessment tools (e.g., Montreal 
Cognitive Assessment (MoCA), Mini-Cog©, Confusion Assessment Method (CAM)). This study 
assessed the potential for P300 auditory evoked potentials (AEPs) obtained using the WAVi 
MedicalTM cognitive screening system to identify and track perioperative brain health in older 
surgical patients to fill a gap in the literature in the quest to discover the ideal perioperative 
cognitive screening tool.  
The study is significant because, long-term, such a device may assist researchers and 
clinicians in determining neurobiomarkers that could be utilized to develop a perioperative brain 
health protection protocol to reduce the incidence and/or severity of perioperative neurocognitive 
disorders, such as postoperative delirium (POD), in older surgical patients. Patients experiencing 
POD present with varying degrees of confusion and inattention. This cognitive state is associated 
with diminished recovery, increased length of stay, higher rates of morbidity and mortality, and 
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escalated health care costs (Saczynski et al., 2012; Koster et al., 2012; Hshieh et al., 
2017; Sprung et al., 2017; Aranake-Chrisinger & Avidan, 2017). 
 Chapter one offers a succinct background on POD and perioperative neurocognitive 
assessment. Concise summaries of the study’s purpose and significance are provided. Brief 
overviews of the study’s theoretical framework and methodology are presented. The chapter 
concludes with the organization of remaining chapters.  
Background 
POD, a state of disorganized thinking and inattention, complicates the postoperative 
recovery of a significant number of surgical patients age 60 years and older (American Geriatrics 
Society, 2015). Patients suffering POD may present as sluggish or restless with impaired 
cognitive function for up to one week following surgery and anesthesia (American Geriatrics 
Society, 2015). A subset of patients, 12-21%, who suffer POD following non-cardiac surgery 
show signs of a postoperative neurocognitive disorder that lasts up to 3 months and 10% 
demonstrate reduced cognitive function one to two years later (Abildstrom et al., 2000; Evered 
and Silbert, 2018). Pediatric and young adult patients may experience emergence delirium for 
approximately thirty minutes following surgery and anesthesia. However, as patients advance in 
age over the age of 60 years, they are more likely to experience POD and associated long term 
cognitive sequelae than are pediatric or young adult patients (Sanders et al., 2011). As such, this 
study focused on older adults. 
Over 30 POD risk factors have been identified making preoperative prediction 
challenging across a wide variety of surgical procedures. POD is problematic because it 
distresses patients, loved ones, and caregivers and is associated with: 1) diminished functional 
recovery, 2) prolonged length of stay, 3) increased care dependency, 4) increased long-term 
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morbidity & mortality, and 5) increased health-care costs (Wu et al., 2019). For these reasons, 
the American Society of Anesthesiologists’ (ASA) Perioperative Brain Health Initiative 
endorses identification of patients at-risk for POD and advocates for research to discover novel 
POD identification, mitigation, and prevention strategies (American Society of 
Anesthesiologists, 2019). 
Research Problem  
Anesthesia providers perform a thorough preoperative assessment of cardiovascular and 
respiratory function by conducting a detailed history and physical examination (e.g. assessing 
metabolic equivalency to task (METs), auscultating the heart and lungs, and reviewing pertinent 
laboratory values). However, limited assessment of anesthesia’s primary target, the brain, is 
routinely performed beyond assessing orientation to person, place, time, and task (i.e., alert and 
oriented times four (A&O x 4)). Crosby et al. (2011) lamented this problem: 
…that we currently make no effort to identify [older patients with a vulnerable brain 
state] preoperatively is an embarrassing state of affairs considering that the brain is a 
principal target of general anesthetic agents, the field of anesthesiology champions 
thorough preoperative evaluation, and perioperative cognitive morbidity in the elderly is 
so common and costly (p. 1267).  
The problem is that no easily-administrable, rapid, reliable, highly sensitive and specific 
assessment of neurocognitive function currently exists to preoperatively identify patients either 
with or at risk for developing a perioperative neurocognitive disorder.  
A POC EEG device capable of rapidly performing easily-administrable, reliable, 
sensitive, and specific neurocognitive assessments at the bedside might enable anesthesia 
providers to better assess baseline neurocognitive function in older surgical patients prior to 
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surgery and anesthesia. Objective assessments derived from such a device may also detect 
neurocognitive changes (e.g., mild or even subsyndromal cognitive impairments) that are 
currently missed in a subset of patients by clinically utilized cognitive assessment tools (e.g., 
MoCA, Mini-Cog©, and CAM) as well as track the progression of patients’ cognitive status to 
determine if, and when, neurocognitive function is improving or worsening perioperatively. 
Gap in the Literature  
The WAVi MedicalTM system is a novel U.S. Food and Drug Administration (FDA)-
cleared POC EEG hardware and software system for rapidly assessing auditory evoked potentials 
(AEPs) to assess cognitive function. AEPs, also known as auditory event-related response tests, 
assess the brain’s response to a novel stimulus and are conducted using an oddball paradigm (van 
Dinteren et al., 2014). An oddball paradigm consists of the presentation of a random assortment 
of auditory stimuli (e.g., combination of high- and low-pitched tones). During AEP testing, 
healthy brains process and respond to a novel stimulus (e.g., high-pitched tones) differently than 
when presented with a series of background stimuli (e.g., low-pitched tones). Variation in the 
brain’s response to a background versus novel auditory stimulus is identifiable in the amplitude 
and latency of EEG waveforms. Brain speed and efficiency are associated with signal latency 
(i.e., the delay in response, measured in milliseconds) on EEG. Brain power and cognitive 
resources are associated with signal amplitude (i.e., the power of a response, measured in 
microvolts).  
Changes in the amplitude and latency of the P300 waveform are associated with altered 
neurocognitive states (Polich, 2004; Sur & Sinha, 2009; Clayton et al. 2020). Specifically, 
reduced P300 amplitude is indicative of a state of neurobiological vulnerability (Sur & Sinha, 
2009). P300 event-related evoked response tests can be used as a neurophysiological marker for 
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even mild neurocognitive disorders (Levada et al., 2016). Yener et al. (2013) demonstrated that 
evoked potential tests can be used to detect mild cognitive impairment. Parra et al. (2012) 
reported that P300 is a “very useful method for the preclinical assessment of [Alzheimer’s 
disease], particularly in populations with low socioeconomic and education levels (p. 1).” AEP 
testing may have utility for assessing and tracking patients’ neurocognitive function in the 
perioperative setting.  
The WAVi MedicalTM system is a unique device that utilizes innovative saline soaked 
fabric electrodes, eSocsTM, to conduct and capture the brain’s electrical activity and an integrated 
artifact detection software system that enhances test-retest and inter-rater reliability when 
conducting POC EEG-based assessments. These system characteristics improve the clinical 
practicality of rapidly performing EEG-based neurocognitive assessments. The WAVi 
MedicalTM system was successfully used to assess baseline cognitive function and track changes 
over time in individuals with traumatic brain injury (Grover et al., 2017; Clayton et al., 2020). 
The WAVi MedicalTM system is currently being used as a neurocognitive assessment tool in a 
National Institutes of Health (NIH)-funded chronic pain study (National Institutes of Health, 
2018). The WAVi MedicalTM system is also being utilized to measure onset and progression of 
cognitive decline in preclinical Alzheimer's patients at the University of Texas at Dallas 
(Clinicaltrials.gov, 2018). The current study is innovative in that the WAVi MedicalTM system 
has never been evaluated as a neurocognitive assessment tool for perioperative neurocognitive 
disorders.  
Theoretical Framework 
The study implements Donabedian’s theoretical model to guide measurement of 
improvement in quality of care (Donabedian, 2005). The three primary constructs used to guide 
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this research were: structure (e.g., attributes of a patient, system, or provider), process (i.e., 
current best practice versus potential new intervention), and outcome (i.e., the end result of 
improvement work). Structure refers to the physical and organizational characteristics where 
healthcare occurs. In this study, structure references the perioperative setting (i.e., the 
preoperative assessment, communication, and education clinic (PACE)), preoperative holding 
area, operating room, post anesthesia care unit, and patient follow-up). Process refers to the care 
provided, and outcome refers to the effect of the intervention. The process-outcome being 
considered is the potential utility of P300 neurobiomarkers versus best medical practice (e.g., 
Montreal Cognitive Assessment (MoCA)) to identify and track perioperative neurocognition in 
older surgical patients. 
Purpose Statement 
The purpose of this study was to explore baseline and postoperative neurocognitive 
characteristics that may help to establish novel predictive and trend metrics for perioperative 
neurocognitive assessment in older surgical patients. These neurobiomarkers might enable a 
more detailed perioperative assessment of a patient’s brain state than do questionnaire-based 
assessment tools. Long-term, these assessments may assist the development of a perioperative 
brain health protection protocol to reduce the incidence and/or severity of perioperative 
neurocognitive disorders in older surgical patients.  
Research Method 
To evaluate the utility of P300 AEPs for assessing and tracking perioperative brain health 
in older surgical patients, the following methodology was used. The study employed a non-
experimental ex post facto secondary data analysis design to retrospectively: 1) compare 
participants’ baseline P300 AEPs to MoCA scores before surgery and anesthesia and 2) evaluate 
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for group differences in pre- to postoperative P300 AEP change scores between participants who 
received two or more potentially neuroprotective multimodal anesthetic adjunct medications 
versus those who did not.  
Data was analyzed using a combination of regression and analysis of variance (ANOVA). 
This study used regression to gauge whether P300 AEPs are predictive of participants’ MoCA 
scores. This study used ANOVA to assess for group differences in change scores (i.e., the 
change from preoperative baseline to postoperative scores) between participants who received 
two or more potentially neuroprotective multimodal anesthetic agents and participants who did 
not.  
Data Source 
Data for this study was extracted from the VCU/VCUHS research electronic data capture 
(REDCap®) database: “Perioperative Brian Health” – PID 22988. Data in this database was 
collected using a longitudinal, repeated measures design to conduct a prospective observational 
trial with a set of pretests and multi-observation post-tests. Preoperative baseline neurocognitive 
assessments were completed using the WAVi MedicalTM software and hardware system and 
MoCA (see Appendix B). Figure 1 depicts the WAVi MedicalTM neurocognitive assessment 
platform.  
Figure 1 




Following surgery and anesthesia, participants underwent postoperative neurocognitive 
assessments using the WAViMedTM system, Mini-Cog©, and CAM. At the time of this study’s 
analysis, the primary study’s database contained 20 participant records. The impact of this 
study’s sample size on statistical conclusion validity was noted and accepted as this was a proof-
of-concept study.  
Research Question, Specific Aims, and Hypotheses    
This study’s research question was: Could P300 AEPs obtained using the WAVi 
MedicalTM system potentially enhance perioperative brain health assessment and provide 
neurobiomarkers that aid in the development of perioperative brain health protection protocols 
for older surgical patients?  
Specific Aim #1: Evaluate the ability of participants’ preoperative baseline P300 
amplitude (i.e., brain power) and P300 latency (i.e., brain speed) to predict participants’ 
cognitive function. This study used regression to understand whether auditory P300 
amplitude (in microvolts) and auditory P300 latency (in milliseconds) predict cognitive 
function among older surgical patients as assessed by MoCA. Each variable was 
considered independently as they measure two separate constructs of neurocognition, 
namely cognitive resources (i.e., brain power) and cognitive efficiency (i.e., brain speed).  
Hypothesis #1: Lower P300 amplitude will be predictive of lower MoCA scores.  
Hypothesis #2: Higher P300 latency will be predictive of lower MoCA scores.  
Specific Aim #2: Evaluate for group differences in pre- to postoperative P300 AEP 
change scores (i.e., amplitude (in microvolts) and latency (in milliseconds)) between 
participants who received two or more potentially neuroprotective multimodal anesthetic 
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adjunct medications (i.e., magnesium, lidocaine, and/or ketamine) versus those who did 
not.  
Hypothesis #3: Participants who received two or more potentially neuroprotective 
multimodal anesthetic agents will demonstrate a larger positive change in their 
P300 amplitude, measured as a pre- to postoperative change score in microvolts. 
Hypothesis #4: Participants who received two or more potentially neuroprotective 
multimodal anesthetic agents will demonstrate a smaller degree of prolongation in 
their P300 latency relative to their baseline, measured as a pre- to postoperative 
change score in milliseconds.  
Study Significance  
This study was important because it demonstrated that the WAVi MedicalTM system 
could be employed as a research tool for neurocognitive assessment within the perioperative 
clinical setting. Pending further investigation, the WAVi MedicalTM system may one day enable 
anesthesia providers to: 1) perform a rapid, valid, and reliable neurocognitive assessment that is 
more sensitive and specific than questionnaire-based cognitive screening tools (e.g., MoCA, 
Mini-Cog©, and CAM), 2) predict POD risk and stratify patients into risk categories, 3) detect 
mild cognitive impairments currently missed by brief cognitive screening tools (e.g., MoCA, 
Mini-Cog©, and CAM), and 4) objectively track the progression of postoperative cognitive 
changes over time. This contribution is significant because a device capable of rapidly and 
reliably predicting, identifying, and tracking perioperative neurocognitive disorders (e.g., POD) 
may enable anesthesia providers to develop and evaluate the effectiveness of perioperative brain 
health protection protocols, clinical pathways, and pharmacologic strategies that reduce the 
incidence and severity of these disorders in older surgical patients. These processes could 
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potentially improve patient outcomes and reduce care costs associated with perioperative 
neurocognitive disorders (Axley & Schenning, 2015). 
Summary of Key Points 
Neurocognitive decline associated with surgery and anesthesia complicates the recovery 
of a subset of older surgical patients (American Geriatrics Society, 2015). POD, the first acute 
event of postoperative neurocognitive impairment, is a public health and research priority of the 
American Society of Anesthesiologists (ASA), American College of Surgeons, American 
Geriatrics Society, American Heart Association, Alzheimer’s Association, and American 
Association of Retired Persons (Mahanna-Gabrielli et al., 2019). The precise mechanism causing 
POD has yet to be elucidated and is likely multifactorial (Wu et al., 2019). What is known is that 
baseline cognitive function is a strong, independent predictor for POD in older surgical patients 
(Culley et al., 2017). POD is a risk factor for long-term neurocognitive decline, and the rate of 
decline is directly proportional the severity of POD (Vasunilashorn et al., 2018).  
The International Perioperative Neurotoxicity Working Group recommends that baseline 
cognitive function be assessed in older surgical patients prior to surgery and anesthesia (Berger, 
et al., 2018). Several cognitive screening tools have been trialed in anesthesia practice (e.g., 
MoCA, Mini-Cog©, and Mini-Mental State Exam (MMSE)) (Berger, et al., 2018). However, 
none of these tools have been widely adopted into routine clinical practice related to validity, 
reliability, and practicality concerns (Berger, et al., 2018). Therefore, the ASA’s Perioperative 
Brain Health Initiative advocates for the identification and evaluation of novel screening tools 
for predicting, identifying, and tracking POD in older surgical patients (American Society of 
Anesthesiologists, 2019).  
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The ideal cognitive screening tool for the preanesthetic assessment of baseline cognitive 
function would be rapid, easily-administrable, valid, reliable, automatically scored, void of 
language, cultural, and education bias and cost-efficient (Axley & Schenning, 2015). No such 
tool has been identified to date. This study systematically evaluated the utility of a novel POC 
EEG hardware and software system, WAVi MedicalTM, for perioperative neurocognitive 
assessment.  
The WAVi MedicalTM system employs auditory event-related response tests as a metric 
of cognition. Leveda et al. (2016) reported that P300 AEPs can be used as a neurobiomarker for 
even mild neurocognitive disorders. Culley et al. (2017) reported that baseline cognitive function 
is a strong, independent predictor for POD in older surgical patients. The WAVi MedicalTM 
system may offer anesthesia providers a rapid and reliable neurocognitive assessment tool that 
could potentially be used to predict, identify, and track the progression of perioperative 
neurocognitive disorders (e.g., POD) in older surgical patients. 
Delimitations    
The data analyzed in this study was sourced from another ongoing research project that 
began data collection in 2020 and plans to continue through a date yet to be determined related to 
unanticipated, unpredictable, and prolonged research restrictions due to COVID-19. The study 
included only data collected within a single health system, VCU/VCUHS. VCU is an urban 
research university that is ranked 32nd in the nation by the NIH for its strength in 
interdisciplinary neuroscience research (Virginia Commonwealth University, 2019). VCUHS is a 
level one trauma and regional referral center that performs ~25,000 surgical procedures each 
year (Virginia Commonwealth University, 2019). Those evaluated in the study consisted of older 
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surgical patients undergoing anesthesia for elective, non-cardiac procedures lasting longer than 
one hour who met eligibility criteria. 
Assumptions 
The principal assumption in this study is that the WAVi MedicalTM system provides valid 
and reliable assessment of P300 waveforms. This assumption was reasonable given: 1) a 
multitude of previous studies utilize P300 evoked potentials as a neurocognitive assessment 
metric, 2) at least two research teams have recently published data captured using the WAVi 
MedicalTM system, and 3) similar ongoing neurocognitive clinical studies are employing the 
WAVi MedicalTM system. Mulkey et al. (2019) accepted similar assumptions as the first 
investigators to evaluate the Ceribell device (Ceribell, Inc., 2018) as a delirium identification and 
assessment tool in the intensive care unit (ICU).  
Definition of Terms 
▪ Cognition: conscious intellectual activity (e.g., thinking, reasoning, remembering)   
▪ Neurocognitive: relating to the central nervous system’s structures and processes that 
enable cognitive functions  
▪ Delirium: a serious, abrupt change in brain function causing confusion and altered 
environmental awareness 
▪ Postoperative delirium (POD): the first acute event of neurocognitive impairment 
occurring up to one week postoperatively or discharge, whichever is first (Evered et al., 
2018) 
▪ Predisposing risk factors: factors that make someone inclined to a condition  
▪ Precipitating risk factors: factors that cause a condition 
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▪ Metabolic derangement: a condition caused by an abnormal metabolic process (e.g., 
diabetes, obesity, hypertension)  
▪ Delayed neurocognitive recovery: cognitive decline with symptoms diagnosed up to one 
month following surgery and anesthesia (Evered et al., 2018) 
▪ Postoperative neurocognitive disorder: cognitive decline with symptoms diagnosed 
between one month and one year post-surgery and anesthesia (Evered et al., 2018) 
▪ Electroencephalography: the measurement of electrical activity in different parts of the 
brain and the recording of such activity as a visual trace  
▪ Point-of-care testing: testing at the place and time patient care is being provided 
▪ Auditory evoked potential: a time-locked electrical signal elicited from the brain in 
response to an auditory stimulus  
▪ Event-related potential: minute changes in the electrical activity of the brain produced by 
a specific event or stimulus  
▪ Amplitude: the maximum distance from equilibrium of a waveform at a given point in 
time 
▪ Latency: the delay between signal initiation and conduction   
▪ Vascular event: abnormal medical condition caused by a critical vascular disease related 
event blocking the delivery of oxygen to body tissues (e.g., stroke or myocardial 
infarction)   
▪ Preoperative: denoting the period before surgery 
▪ Intraoperative: denoting the period during surgery 
▪ Postoperative: denoting the period following surgery 
▪ Perioperative: denoting the period before, during, and following surgery  
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▪ Anesthetic depth: the degree an anesthetic medication depresses the central nervous 
system 
Organization of Remaining Chapters 
The remainder of this study is organized into five chapters, a bibliography, and 
appendices. Chapter 2 presents a comprehensive synthesis of the literature. Chapter 3 describes 
the study’s guiding theory. Chapter 4 explains the study design and research methodology. The 
WAVi MedicalTM system, the data source’s study protocol, and sample determination are 
delineated. Data analysis and discussion of study findings are offered in chapter 5 following the 
study. Chapter 6 provides a summary of key points, conclusions, and recommendations. 





















Chapter 2: Literature Review 
Chapter Overview 
Chapter two reviews literature related to perioperative neurocognitive disorders, 
specifically risk factors, perioperative cognitive assessment, and associated postoperative 
sequelae. The chapter provides a historical background for this study, defines postoperative 
delirium (POD), and reviews the current state of the science of perioperative brain health. A gap 
in the literature is established, and aims and hypotheses are presented.  
Anesthetics and The Brain 
Anesthetics are believed to exert their effects by altering the brain’s ability to make 
neuronal connections (i.e., communicate from one brain cell to another) (Flood & Shafer, 
2015a). Neuronal connections are the physical basis for consciousness (Pepperell, 2018). Brain 
cells communicate with one another by sending neurotransmitters (i.e., chemical messenger 
molecules) across the gaps that exist between cells (Flood & Shafer, 2015b). These gaps are 
called as synapses or junctions. When one brain cell sends a signal to another brain cell, 
neurotransmitters (e.g., acetylcholine, dopamine, norepinephrine, gamma aminobutyric acid 
(GABA), glutamate, glycine, galanin, etc.) are released in response to an action potential (Flood 
& Shafer, 2015b). An action potential is a change in the cell’s electrical potential caused by the 
movement of ions (e.g., sodium, potassium, calcium, chloride, etc.) (Flood & Shafer, 2015b). 
Anesthesia providers administer medications that alter one or more of these neuronal 
communication processes (Purdon et al., 2015). Following anesthesia, these neuronal 
connections may not return to patients’ baseline levels in older adults as rapidly or completely as 
 
 16 
they do in younger adults (Berger et al., 2018; Mahanna-Gabrielli et al., 2019; Wu et al., 2019; 
Wu et al., 2019).  
Anesthesia is necessary when a patient requires surgery. However, exposing the aged 
brain to an anesthetic (e.g., intravenous, inhaled, or regional) may contribute to transient and/or 
long-lasting neurocognitive impairment (Berger et al., 2018; Mahanna-Gabrielli et al., 2019; Wu 
et al., 2019Wu et al., 2019). For this reason, perioperative neurocognitive disorders are a major 
brain health related concern for older surgical patients (American Society of Anesthesiologists, 
2019; Berger et al., 2018; Mahanna-Gabrielli et al., 2019).  
Historical Background 
On October 16, 1846 William Thomas Green Morton publicly demonstrated the use of 
inhaled ether as an effective anesthetic in the Bulfinch Building, now known as the Ether Dome, 
at Massachusetts General Hospital in Boston, Massachusetts (Fenster, 2002). Morton 
administered ether to Edward Abbott for the surgical removal of a mass on Abbott’s neck 
(Fenster, 2002). Abbott calmly awoke from surgery and his surgeon, Dr. John Collins Warren, 
then Dean of Harvard Medical School, famously remarked “Gentleman, this is no humbug” 
(Fenster, 2002). Since that famous day, the pain and suffering associated with surgery have been 
attenuated like never before. Anesthetics remarkably and reversibly reduce a patient’s state of 
consciousness to facilitate surgery. However, whether or not the brain returns to a state identical 
to its presurgical, preanesthetic state in vulnerable patients (e.g. older patients) following surgery 
and anesthesia has been questioned for over 130 years and increasingly critically examined for 
the past decade (Savage, 1887; Berger et al., 2018; Mahanna-Gabrielli et al., 2019). 
Savage, a psychiatrist, was one of the first physicians to describe an altered brain state in 
patients following surgery and anesthesia in his presentation at the Annual Meeting of the British 
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Medical Association in Dublin, Ireland in 1887. At this meeting he made the case that 
postoperative neurocognitive disorders may not be a humbug either. Interestingly, Savage (1887) 
opened his presentation by stating:  
All writers and observers have noticed that it is very rarely that one cause alone is 
efficient for the production of any attack of insanity, and that usually there are several 
predisposing causes which may have been in operation for a long time [emphasis added], 
as well as one or more exciting causes which may have been in action for much shorter 
periods...[t]he most common form of mental disorder which comes in such cases is of the 
type of acute delirious mania…though such mental disorder is generally of a temporary 
character, it may pass into chronic weak-mindedness, or it may pass into (c) progressive 
dementia which cannot be distinguished from general paralysis of the insane…any cause 
producing delirium may produce a more permanent disorder of the mind [emphasis 
added]. (p. 1405)  
One notable case presented by Savage (1887) was of an “elderly” (age not specified) clergyman 
who presented for surgery for rectal cancer. Following an uneventful ether anesthetic and 
operation, the patient’s surgeon, Mr. Croft, noted:  
[W]hen the patient became conscious, it was at once noticed that his mind was 
affected…[h]e was restless, incoherent, repeating meaningless expressions…[h]is 
memory seemed very defective…he remained in this state for a few weeks after his 
return home, and then almost suddenly recovered [emphasis added]. (p. 1406)  
In another case, Savage (1887) described a young mother who experienced an altered mental 
state beginning several hours after the administration of a nitrous oxide-based anesthetic for 
dental surgery:   
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[T]he patient [was] delirious, conjunctivae insensible, urine and feces passed 
involuntarily; irregular movements of all kinds were being made, and speech was 
incessant…[s]he never regained her senses or recognized her friends. She was in a state 
of delirious mania for three weeks, then settled into dementia, in which she 
[remained]…[t]he points of this case are the acquired nervous instability, the acute 
delirious mania, with its consecutive dementia [emphasis added]. (p. 1406) 
Savage concluded by stating “I trust that enough evidence has been brought forward to induce 
others to give their experience, and thus establish a relation or destroy a fallacy [emphasis 
added]” (p. 1406). Sixty-eight years passed before Bedford (1955) formally and systematically 
did so—establish a relation.  
Bedford (1955) affirmed “It is well known, too, that in elderly people transitory 
confusional states often follow operations under general anesthesia; but it is not so widely 
appreciated that minor dementias and even permeant catastrophic mental impairment may 
occasionally be the aftermath” (p. 6884). For this reason, Bedford systematically reviewed the 
medical records of “…4250 patients over the age of 65 seen in the Oxford geriatric unit at 
Cowley Road Hospital in the five years ending in June, 1954…1193 had undergone some 
operation under general anesthesia…” (p. 6884). Bedford (1955) found that thirty-four percent 
(410 / 1,193) of these older surgical patients had friends and family members who described that 
“the patient “had never been the same since operation”” (p. 6884). Bedford identified evidence to 
dispute this allegation in 290 / 410 patients, and then carefully evaluated the remaining 120 cases 
in which there were reports such as:  
"He’s never been able to write a decent letter since...[anesthesia and surgery]"  
"He’s become so forgetful since ..."  
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"She can’t be trusted to go out shopping since..."  
"She’s lost all interest in the family since..."  
"He’s never read a book through since..."  
"He used to be so tidy but now he’s neglectful and sloppy in his habits [since]...” 
"He can’t concentrate on anything since..."  
"She’s become childish and unreliable since..."  
"He’s not been able to attend to the business since..."  
"He’s just not the same person since ..." (p. 6884)  
Bedford’s (1955) report followed these anecdotal statements with 18 case-histories of 
patients in which Bedford personally observed a patient’s change in mental state from 
preoperative baseline health to extreme cases of postoperative dementia “…in which the patient 
became virtually a human vegetable…” following surgery and anesthesia (p. 6884). It is 
important to note that Bedford (1955) supported his rationale for only including the 18 cases that 
he personally observed in his analysis by stating:  
First, the patient’s testimony may be unreliable because of his dementia…[and] 
[s]econdly, relations and friends tend to blame any dramatic incident, such as an 
operation or accident, for the dementia which has in fact been slowly progressive 
intellectual degradation, antedating to the operation or accident…hence the incident is 
blamed, albeit falsely, for the dementia [emphasis added]. (p. 6884) 
Another decade passed before rigorous evaluation of cognitive changes following cardiac 
surgery began in the 1960s (Evered et al., 2016).  
An ardent academic interest in cognitive dysfunction at that time largely occurred in 
response to a series of reports implicating the cardiopulmonary bypass machine as a potential 
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causative mechanism for altered neurocognition following open-heart surgery (Blachy & Starr, 
1964; Egerton & Kay, 1964; Heller et al., 1970; Kornfeld et al., 1965). Shaw et al., (1987) 
conducted one of the first prospective studies to evaluate perioperative cognitive function in 259 
patients prior to, one week after, and six months following cardiac surgery using a battery of 10 
neuropsychological tests. Following multivariate analysis of 91 potential contributory mechanisms, 
only “cardiac failure before surgery and global impairment of left ventricular function” correlated 
with long-term neurocognitive decline (Shaw et al., 1987). More recent evidence also demonstrates 
that cardiopulmonary bypass alone does not cause neurocognitive dysfunction following open-
heart surgery (Soenarto et al., 2018). A significant number of older surgical patients present with 
postoperative neurocognitive alterations following an array of both cardiac and non-cardiac 
surgeries (Rudolph & Marcantonio, 2011). Table one lists 84 studies conducted over the last fifty 
years reporting the wide-ranging, but significant incidence of cognitive changes in older surgical 
patients following a variety of surgical procedures.  
Table 1 
Reported Incidence of Cognitive Changes Following a Variety of Surgical Procedures  
Type of Surgery Incidence of Postoperative 
Cognitive Changea 
Reference  
Cardiac 41% Egerton & Kay, 1964 
Cardiac 19% McClish et al., 1968 
Cardiac 17% Kimball, 1969 
Cardiac 31% Rubenstein & Thomas, 1969 
Cardiac 25% Heller et al., 1970 
Cardiac 24% Morgan, 1971 
Cardiac 74% Kimball, 1972 
Cardiac 66% Frank et al., 1972 
Cardiac 59% Freyhan et al., 1971 
Cardiac 31% Kornfield et al., 1974 
Cardiac 28% Kornfield et al., 1978 
Cardiac 23% Summers, 1979 
Cardiac 72% Sadler, 1981 
General 18% Millar, 1982 
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Table 1 Continued 
 
Cardiac 68% Owens & Hutelmyer, 1982 
Orthopedicb  52% Williams et al., 1985 
Urologic 7% Chung et al., 1987 
Orthopedic 
(hip fracture) 
43% Gutstafson et al., 1988 
Cardiac 0% Schindler et al., 1989 
Orthopedic 28% Rogers et al., 1989 
Urologic 5% Chung et al., 1989 
Lung Transplant 73% Craven et al., 1990 
All 10% Egbert et al., 1990 
Orthopedic 53% Gufstafson et al., 1991 
Orthopedic 48% Gufstafson et al., 1991 
Orthopedic 41% Williams-Russo et al., 1992 
Vascular 10% Marcantonio et al., 1994 
Orthopedic 9% Marcantonio et al., 1994 
Cardiac 
(aortic aneurysm) 
41% Marcantonio et al., 1994 
Thoracic 
(noncardiac) 
14% Marcantonio et al., 1994 
Abdominal 5% Marcantonio et al., 1994 
Orthopedic 9% Marcantonio et al., 1994 
Orthopedic 18% Fischer & Flowerdew, 1995 
Orthopedic 
(hip fracture) 
47% Bowman, 1997 
Orthopedic 27% Bowman, 1997 
Gastrointestinal 17% Kankeo et al., 1997 
Orthopedic  10% Litaker et al., 1998 
Orthopedic 11% Lynch et al., 1998 
Orthopedic 
(hip fracture) 
11% Edlund et al., 1999 
Orthopedic 5% Silverstein et al., 1999 
Orthopedic 
(hip fracture) 
5% Brauer et al., 2000 
Orthopedic 
(hip fracture) 
24% Duppils et al., 2000 
Orthopedic 12% Duppils & Wikblad, 2000 
Orthopedic 20% Andersson et al., 2001 
Orthopedic 5% Andersson et al., 2001 
Orthopedic  
(hip fracture) 
41% Galanakis et al., 2001 
Orthopedic 
(hip fracture) 
27% Edlund et al., 2001 
Orthopedic  15% Galanakis et al., 2001 
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Table 1 Continued 
 
Vascular 36% Schneider et al., 2002 
Cataract 4% Milstein et al., 2002 
Orthopedic 
(hip fracture) 
4% Johansson et al., 2002 
Orthopedic 
(hip fracture) 
53% Thakur et al., 2002 
Orthopedic 28% Zakriya et al., 2002 
Orthopedic 10% Linstedt et al., 2002 
Vascular 39% Böhner et al., 2003 
Orthopedic 
(hip fracture) 
14% Morrison et al., 2003 
Orthopedic 
(hip fracture) 
20% Schuurmans et al., 2003 
Orthopedic 
(hip fracture) 
28% Forminga et al., 2003 
Orthopedic 
(hip fracture) 
50% Zakriya et al., 2004 
Orthopedic 
(hip fracture) 
6% Kagansky et al., 2004 
Orthopedic  9% Jankowski et al., 2004 
Orthopedic 15% Kudoh et al., 2004 
Vascular 33% Benoit et al., 2005 
Abdominal  51% Olin et al., 2005 
Orthopedic 14% Freter et al., 2005 
Spine 4% Kawaguchi et al., 2006 
Orthopedic 21% Bickel et al., 2008 
Vascular 22% Kantznelson et al., 2009 
Abdominal 25% Morimoto et al., 2009 
Spine 14% Lee & Park, 2009 
Spine 7-28% Ushida et al., 2009 
Vascular 23% Koebrugge et al., 2010 
Vascular 29% Sasajima et al., 2012 
Vascular 25% Kawatani et al., 2015 
Vascular 5% Visser et al., 2015 
Vasular 15% Raats et al., 2015 
Vascular 17% Raats et al., 2015 
Vascular 12% Sugimoto et al., 2015 
All 2% Lin et al., 2016 
Orthopedic  
(hip fracture)  
71% Watne et al., 2016 
Spine 8% Soh et al., 2017 




Table 1 Continued 
 
Spine 18% Kang et al., 2020 
Non-cardiac  12% Iamaroon et al., 2020 
Note: Studies are listed in chronological order. 
 
a: Reported incidence (%) of postoperative cognitive change is rounded to nearest whole number 
 
b: Orthopedic refers to elective procedures (e.g., hip or knee arthroplasty) unless otherwise 
specified 
Postoperative cognitive changes in older surgical patients have been reported following 
general anesthesia, sedation, and spinal anesthesia (Evered et al., 2011; Ilango et al., 2016; Patel 
et al., 2018). Miller et al. (2018) conducted a systematic review of 28 randomized controlled 
trials (RCTs) totaling 4,507 patients across a variety of surgical procedures and concluded that 
current best evidence is also inconclusive as to whether or not the incidence of POD varies 
between patients receiving general anesthesia with inhalational anesthetics (e.g., isoflurane, 
sevoflurane, desflurane) versus intravenous anesthetics (e.g., propofol), but reported “with low-
certainty” that postoperative cognitive dysfunction may be reduced when patients receive a 
propofol-based total intravenous anesthetic (p. 2).  
Ehsani et al. (2020) recently reported a lower incidence of postoperative cognitive 
dysfunction and delirium following spinal anesthesia (4.25%) versus general anesthesia (29.7%) 
in a small cohort of 94 patients over the age of 50 years presenting for hip fracture fixation 
indicating that further inquiry is still needed related to assessment techniques and potential 
contributory mechanisms. One thing is for certain, a growing body of research continues to 
investigate whether or not the brain returns to an identical preanesthetic state in vulnerable 
patients (e.g., patients age 60 years and older) following surgery and anesthesia (Berger et al., 
2018; Mahanna-Gabrielli et al., 2019; Wu et al., 2019). 
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Heterogeneity of Prior Studies 
As one can observe from Table one, the reported incidence of neurocognitive changes 
following surgery in a single patient population (e.g., orthopedic hip fracture repair) varies 
significantly (5-71%). Reported explanations for this strikingly wide range center around the 
significant heterogeneity of these studies (Bruce et al, 2007; Evered et al., 2018; Rudolph & 
Marcantonio, 2011). Sample populations, assessment tools, and assessment epochs varied greatly 
among the studies (Bruce et al, 2007; Evered et al., 2018; Rudolph & Marcantonio, 2011).  
As an example, in the 17 studies evaluating neurocognitive changes following hip 
fracture repair listed in Table one, six different assessment tools were used including: Neecham 
Confusion Scale (1 study), CAM (8 studies), Diagnostic and Statistical Manual of Mental 
Disorders (DSM) editions 3 and 4 (7 studies), Organic Brain Disorders assessment (4 studies), 
and the Delirium Rating Scale (1 study). Eleven of these studies employed a single assessment 
scale, and six incorporated two assessment scales. Sample sizes ranged from 10 to 546 study 
participants. The mean age of study participants, when reported, ranged from 65-92. Varied 
assessment epochs across these studies included: daily, twice daily, postoperative days 1 or 2 and 
at discharge, postoperative day 5 only, and postoperative day 7 only. Similarly, in patients 
presenting for cardiac surgery “…the incidence of delirium using chart review was 3%, noted 
during routine clinical care was 8%, using interviews with nurses was 9%, and using daily 
mental status testing and application of a validated diagnostic algorithm was 53%” (Evered et al., 
2018, p. 874). 
Another major barrier to comparing data from prior postoperative cognition studies is the 
varied operationalization of study terms (e.g., confusion, delirium, postoperative cognitive 
dysfunction) (Evered et al., 2018). For this reason, recommendations for standardized 
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nomenclature of cognitive changes following surgery and anesthesia were proposed by Evered 
and colleagues in 2018 (Evered et al., 2018). These recommendations were developed using “a 
modified Delphi procedure with no prespecified number of rounds comprised of three face-to-
face meetings followed by online editing of draft versions” by a multispecialty working group 
(Evered et al., 2018, p.872). The recommendations propose a shift away from a previously used 
umbrella term, postoperative cognitive dysfunction, to a well-defined time and score-grouped 
classification system of perioperative neurocognitive disorders (Evered et al., 2018; Mahanna-
Gabrielli et al., 2019). Evered et al.’s (2018) recommended classification system for 
perioperative neurocognitive disorders categorized according to the timing of onset of the 
disorder is summarized by Figure 2.  
Figure 2 
 
Standardized Nomenclature of Perioperative Neurocognitive Disorders 
 
 
Note: Image adapted from Mahanna-Gabrielli et al. (2019). 
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This study incorporated neurocognitive assessments that were performed at patients’ 
baseline and postoperative day one to explore baseline and postoperative neurocognitive 
characteristics that may help to establish novel predictive and trend metrics for perioperative 
neurocognitive assessment in older surgical patients. 
Postoperative Delirium (POD) 
The clinical diagnosis of delirium was first standardized by the American Psychiatric 
Association in their Diagnostic and Statistical Manual of Mental Disorders (DSM) 3rd edition 
(Oosterhous et al., 2017). The DSM is an authoritative guide used by healthcare professionals 
worldwide to diagnosis mental disorders (American Psychiatric Association, 2021). Delirium is 
an acute change in global cognitive function and attention that presents with varying symptoms 
and results from an organic etiology (Mulkey et al., 2018). POD is a term used to describe the 
first acute event of neurocognitive impairment, that aligns with the DMS-5 criteria, occurring up 
to one week following surgery and anesthesia or prior to hospital discharge, whichever occurs 
first (Evered et al., 2018). Evered et al. (2018) were the first to operationalize the term POD 
based on DSM-5 criteria and recommend this standardized nomenclature be used in research and 
clinical practice. DSM-5 delirium criteria are listed in Table two (American Psychiatric 
Association, 2013).  
POD presents as an acute onset of altered executive functions. The term executive 
functions refers to one’s ability to learn, think, reason, remember, problem solve, decide, and pay 
attention. These cognitive processes essentially define one’s ability to organize and participate in 
daily activities. A patient experiencing POD may be tired and sluggish (i.e. present with 
hypoactive delirium), restless and distressed (i.e., present with hyperactive delirium), or a 




Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Delirium Criteria 
A Disturbance in attention (i.e., reduced ability to direct, focus, sustain, and shift attention) 
and awareness (reduced orientation to the environment). 
B The disturbance develops over a short period of time (usually hours to a few 
days), represents an acute change from baseline attention and awareness, and tends to 
fluctuate in severity during the course of a day. 
C An additional disturbance in cognition (e.g. memory deficit, disorientation, language, 
visuospatial ability, or perception). 
D The disturbances in Criteria A and C are not better explained by a pre-existing, 
established or evolving neurocognitive disorder and do not occur in the context of a 
severely reduced level of arousal such as coma. 
E There is evidence from the history, physical examination or laboratory findings that the 
disturbance is a direct physiological consequence of another medical condition, substance 
intoxication or withdrawal (i.e. due to a drug of abuse or to a medication), or exposure to 
a toxin, or is due to multiple etiologies. 
 
Society, 2015). Hypoactive delirium accounts for ~50% of delirium cases, mixed hypo- and 
hyperactive delirium for ~30% of cases, and hyperactive delirium for only 20% of cases (Hosker 
& Ward, 2017). 
Over 50% of patients who experience postoperative delirium present with signs of 
delirium on postoperative day one (Iamaroon et al., 2020; Lin et al., 2016). However, the most 
common presentation of delirium, the hypoactive form, is more difficult to identify in clinical 
practice and for this reason often goes undiagnosed (Collins, 2010; Hosker & Ward, 2017). 
Figure 3 differentiates the clinical signs and symptoms hyper- versus hypoactive delirium.  
POD is believed to present with varied and fluctuating symptoms that can differ from 
patient to patient as the result of increased dopamine, decreased acetylcholine, and divergent 
amalgamations of other neurotransmitters (e.g., norepinephrine, glutamate, serotonin, and 








A Visual Summary Differentiating Hyperactive Versus Hypoactive Delirium 
 
Note: Image adapted from Hosker & Ward (2017). 
 
Incidence 
According to the American Geriatrics Society (2015), 19 million older adults in the 
United States (US) present for surgery and anesthesia each year, and 4.5-9 million (~25-50%) of 
these patients experience POD following surgery. The highest reported incidence of POD in a 
prospective sample of older surgical patients is 71% (Watne et al., 2016). However, the reported 
incidence varies greatly (2-71%) throughout the literature largely related to the significant 
heterogeneity among studies as previously discussed. Table one lists examples. The challenge in 
clinically identifying the hypoactive form of delirium may also have led to the relatively low 
reported incidence of POD in some studies (Hosker & Ward, 2017; Olotu, 2019). Collins et al. 
(2010) reported that 72% of patients who met criteria for a clinical diagnosis of delirium were 
unidentified when presenting with hypoactive signs. Regardless, POD is the most prevalent 
complication associated with surgery and anesthesia among older adult patients (American 
Geriatrics Society, 2015; American Society of Anesthesiologists, 2019). 
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Of additional concern is that a subset of patients who experience POD, 12-21%, 
following non-cardiac surgery develop a postoperative neurocognitive disorder lasting up to 3 
months, and 10% exhibit reduced cognitive function one to two years later (Abildstrom et al., 
2000; Evered & Silbert, 2018). POD is problematic because the condition distresses patients, 
their loved ones, and care providers; it is also associated with inferior functional recovery, and 
increased healthcare spending (Hernandez et al., 2017; Hshieh et al., 2017; Inouye et al., 2014; 
Zywiel et al., 2015). 
Sequelae Associated with Postoperative Delirium (POD) 
Patients experiencing POD present with varying degrees of consciousness (e.g., hyper- or 
hypoactive) and demonstrate a combination of intellectual, attention, and memory-related 
impairments (Inouye et al., 2014; Munk et al., 2016). This state of disorganized thinking and 
inattention not only distresses patients, family members and caregivers, but is also associated 
with increased length of hospitalization, patient morbidity and mortality, and progression to 
delayed or incomplete neurocognitive recovery (Jin et al., 2020; Koster et al., 2012; Saczynski et 
al., 2012). Based on a prospective observational study of 566 older patients presenting for 
elective surgery, Hshieh et al. (2017) concluded that POD was associated with “clinically 
meaningful impairment of functional recovery” for up to 18 months postoperatively (p. 647). 
Koster et al. (2012) reported that delirium following elective cardiac surgery is associated with a 
seven-fold increased mortality risk, a nearly two-fold increase in the likelihood of hospital 
readmission, and a reduction in patients’ quality of life in a sample of 300 patients.  
POD is also associated with delayed neurocognitive recovery and may be predictive of 
postoperative neurocognitive disorders (Sprung et al., 2017). Bickel et al. (2008) followed 41 
patients who experienced POD following hip surgery and reported that 53.8% of these patients 
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experienced cognitive impairment 38 months after surgery. Additionally, “[l]ogistic regression 
analysis adjusted for age, sex, medical comorbidity and preoperative cognitive performance 
revealed highly significant associations between delirium and cognitive impairment (OR = 41.2; 
95% CI = 4.3-396.2), subjective memory decline (OR = 6.2; 95% CI = 1.5-25.8), and incident 
need for long-term care (OR = 5.6; 95% CI = 1.6-19.7)” (Bickel et al., 2008, p. 26). Patients who 
experience POD are also more likely to be diagnosed with dementia or experience long-term 
cognitive decline than patients who have not experienced POD (Aranake-Chrisinger & Avidan, 
2017; Saczynski et al., 2012; Sprung et al., 2017; Vasunilashorn et al., 2018). Whether POD 
contributes to or is evidence of impending dementia is unclear.  
Leslie et al. (2008) reported that patient care costs more than double in hospitalized 
patients with delirium (Leslie et al., 2008). Inouye et al. (2014) reported that annual delirium 
costs exceed $164 billion in the US and $182 billion in Europe. Zyweil et al. (2015) reviewed a 
surgical database from a single urban academic medical center to investigate the impact of POD 
on health care costs in 242 older patients after hip fracture surgery. POD was associated with an 
average cost increase of $8,286 dollars per patient, and the total increased cost associated with 
POD over the course of the two-year study was $961,131 dollars (Zyweil et al., 2015). Table 
three lists postoperative sequelae associated with POD.  
Risk Factors  
Over 30 predisposing and precipitating risk factors for POD have been reported. They are 
summarized in Table four (Mahanna-Gabrielli et al., 2019). Several risk assessment and POD-
prediction tools have recently been proposed for use during the preoperative anesthetic 
assessment in an effort to risk-stratify older surgical patients and efficiently allocate limited 




Postoperative Sequelae Associated with Postoperative Delirium (POD) 
Postoperative Sequelae  
- Distress for patients, loved ones, and caregivers (Koster et al., 2012) 
- Diminished functional recovery (Koster et al., 2012) 
- Prolonged length of stay (Raats et al., 2015) 
- Increased care dependency (Hshieh et al., 2017) 
- Increased long-term morbidity risk (Gleason et al., 2016) 
- Risk of long-term cognitive decline (Aranake-Chrisinger & Avidan, 2017) 
- Increased mortality risk (Maniar et al., 2016; Raats et al., 2015) 











Invasiveness of surgery 
Impaired vision or hearing Malnutrition Intensive care unit admission 
Severe illness Depression Postoperative infection 
Preoperative infection Alcohol abuse Vascular events 
Poor functional status  Sleep disturbances Anesthetic depth 
Metabolic derangements History of delirium Perioperative stress 
Polypharmacy Unidentified genetic factors Dehydration 
Pain Longer duration of surgery Urgency of Surgery 
Age > 60 years 
 
determined because they have either been developed in medical, rather than surgical, patient 
populations (e.g., Iounye et al., 1993) or yet to be validated outside of a single surgical procedure 
(e.g., Kalisvaart et al., 2006 and Kim et al., 2020). One tool, the Delirium Prediction Based on 
Hospital Information (DELPHI), was validated in a small sample of 553 patients undergoing 
trauma, vascular, or abdominal surgery at a single medical center (Kim et al., 2016). Risk factors 
incorporated into the DELPHI model were: age, low physical activity, hearing impairment, 
heavy alcoholism, history of prior delirium, ICU admission, emergency surgery, open surgery, 
and increased preoperative C-reactive protein (Kim et al., 2016). However, the DELPHI’s 
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predictive value in this small single-center study was only 70%, and the tool has yet to be 
externally validated (Jin et al., 2020).  
Mitigation Strategies  
Delirium is reportedly preventable in up to 40% of patients (Siddiqi et al., 2016). In an 
effort to prevent delirium, the American Geriatrics Society (2015) recommends that anesthesia 
providers “avoid medications that induce delirium postoperatively in older adults (p. 140).” 
According to the American Geriatrics Society (2015), these medications include: drugs with 
anticholinergic properties (e.g., famotidine— a commonly used perioperative histamine (H2-
receptor) antagonist), corticosteroids (e.g., dexamethasone— a commonly used antiemetic and 
anti-inflammatory), meperidine, sedative hypnotics (e.g., midazolam— a commonly used 
preoperative sedative and anxiolytic), and polypharmacy (i.e. combining five or more 
medications— which is a common practice as part of enhanced recovery after surgery (ERAS) 
protocols). Unfortunately, all medications commonly utilized to produce general anesthesia (e.g., 
propofol, sevoflurane, desflurane, and isoflurane) have been associated with the development of 
POD in older surgical patients (Kinjo et al., 2019; Sieber et al., 2018). Additionally, Patel et al. 
(2018) reported that, based on the limited evidence available, regional anesthesia (i.e., the 
injection of local anesthetics in proximity to a target nerve to block pain impulses from a region 
of the body) versus general anesthesia does not reduce the incidence of POD in older patients 
following hip fracture surgery.  
Providers, however, cannot omit every anesthetic agent and technique when an older 
patient requires surgery. Rather than omitting anesthetics agents, emerging research is 
considering the possibility that co-administering potentially neuroprotective anesthetic adjunct 
medications may preserve or perhaps even enhance patients’ neurocognitive function. Messick et 
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al. (1987) defined neuroprotection as the “prevention or amelioration of neuronal damage 
evidenced by abnormalities in cerebral metabolism, histopathology or neurologic function 
occurring after a hypoxic or an ischemic event” (as cited in Hudetz et al., 2010, p. 131). Hudetz 
et al. (2010) described the two goals of neuroprotection: 1) prevent cerebral ischemia and 2) 
promote the recovery of ischemic neuronal tissue. Examples of potentially neuroprotective 
anesthetic adjunct medications reported in the literature include ketamine, magnesium, and 
lidocaine.  
Rascón-Martínez et al. (2016) evaluated the impact of intraoperative ketamine on 
postoperative neurocognitive function in a sample of 65 older patients undergoing ophthalmic 
surgery. The investigators evaluated participants’ cognitive function pre- and post-operatively 
using the Short Portable Mental Status Questionnaire (SPMSQ) (Rascón-Martínez et al., 2016). 
Participants either received 0.3mg/kg ketamine intraoperatively or placebo (Rascón-Martínez et 
al., 2016). Baseline preoperative SPMSQ scores were similar for both study groups (Rascón-
Martínez et al., 2016). However, participants who received intraoperative ketamine demonstrated 
improved SPMSQ scores relative to their baseline (Rascón-Martínez et al., 2016). The 
postoperative SPMSQ scores of participants who received the placebo were essentially 
unchanged from baseline (Rascón-Martínez et al., 2016). A systematic review and meta-analysis 
by Hovaguimian et al. (2018) concluded that ketamine seemed to lower the risk of postoperative 
cognitive dysfunction [RR 0.34, 95% CI [0.15, 0.73]], but not the risk for POD [RR 0.83, 95% 
CI [0.25, 2.80]]. However, the quality of available evidence for this review was deemed to be 
low to very-low (Hovaguimian et al., 2018). The authors advocated that future research is needed 
to “further clarify the efficacy of ketamine on neurocognitive outcomes” (p. 1182).   
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Bilotta et al. (2013) conducted a qualitative review of RCTs to identify potentially 
neuroprotective perioperative pharmacological strategies. The authors identified two trials 
demonstrating that intraoperative lidocaine infusions were neuroprotective, and two trials 
concluding that intraoperative lidocaine infusions failed to offer neuroprotection (Bilotta et al., 
2013). The two trials that did not demonstrate a neuroprotective effect may have failed to do so 
as a result of “…too short of an infusion period, an excessively high dose, or having included 
diabetic patients who might be at an increased risk of neurological injury or a different 
sensitivity to lidocaine” (Bilotta et al., 2013, p. 115). A more recent RCT comparing 
intraoperative lidocaine infusions to normal saline placebo reported that lidocaine infusions 
attenuated postoperative cognitive impairment in older patients following spine surgery (Chen et 
al., 2015). Similar to ketamine, further research is needed to elucidate the potential perioperative 
neuroprotective effects of lidocaine infusions.  
Magnesium is also identified in the literature as a potentially neuroprotective anesthetic 
adjunct medication. Bhudia et al. (2007) enrolled 350 participants in an RCT comparing 
postoperative neurocognition between participants who received magnesium versus placebo 
during cardiac surgery. The authors identified that the magnesium group demonstrated better 
short-term postoperative cognitive function, notably in short-term memory, than the placebo 
group (Bhudia et al., 2007). Mack et al. (2009) conducted a double-blind placebo-controlled trial 
to evaluate the neuroprotective potential of intraoperative magnesium administration in 108 older 
surgical patients (mean age of 68 years) undergoing carotid endarterectomy. The authors 
reported that participants in the magnesium group demonstrated less postoperative cognitive 
decline than those receiving placebo [OR 0.09, 95% CI 0.02-0.5, p<0.01] (Mack et al., 2009).  
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 While available evidence is limited in both number and quality, the potential 
neuroprotective effects of ketamine, lidocaine, and magnesium warrant further inquiry. Of 
particular interest, and yet to be evaluated in the setting of postoperative delirium in older 
surgical patients, is the possible synergistic effect of potentially neuroprotective anesthetic 
adjunct medications. Mendonca et al. (2020) reported a positive synergistic effect using a 
combination of lidocaine and magnesium for perioperative pain management. Fang et al. (2020) 
reported that combining lidocaine with ketamine “may be beneficial in shortening the onset of 
anesthesia, promoting postoperative awaking…and [reducing the] incidence of adverse 
reactions” compared to administering ketamine alone (p. 1). These findings were based on a 
case-control study of 586 pediatric patients (Fang et al., 2020). It is possible that similar 
synergistic effects exist related to neuroprotection in older surgical patients.  
Potential benefits of varied pharmacological treatment strategies are challenging to 
ascertain when 1) the etiology of POD is not fully understood and 2) clinically utilized 
questionnaire-based neurocognitive assessment tools (e.g., MoCA, Mini-Cog©, and CAM)) 
provide a simple estimate of gross neurocognitive function, and 3) the accuracy and utility of 
questionnaire-based neurocognitive assessments are questionable in certain subpopulations, such 
as African American patients as well as patients with low socioeconomic and education levels. 
This study evaluated for mean group differences in potential EEG-based postoperative 
neurocognitive biomarkers (i.e., P300 amplitude and latency) between participants who received 
two or more potentially neuroprotective anesthetic adjunct medications and those who did not. 
Pathophysiology 
The pathophysiology of delirium is not fully elucidated. Available evidence is largely 
derived from animal models as human studies are limited (Jin et al., 2020). Prominent etiological 
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hypotheses include: 1) the neurotransmitter hypothesis, 2) the stress response hypothesis, 3) the 
neuroinflammation hypothesis, 4) the Alzheimer acceleration hypothesis, and 5) the cerebral 
vascular hypothesis, 6) metabolic derangements, 7) electrolyte imbalances, 8) and genetic factors 
(Inouye et al., 2014; Mahanna-Gabrielli et al., 2019; Jin et al., 2020). These hypotheses more 
likely complement rather than compete with one another as the etiology of delirium is likely 
multifactorial (Inouye et al., 2014; Mahanna-Gabrielli et al., 2019; Jin et al., 2020). Table five 
summarizes these hypotheses. 
Table 5 
A Summary of Etiological Hypotheses for Delirium 
Hypothesis Brief Description  
1. Neurotransmitter 
Hypothesis 
Altered levels of circulating neurotransmitters (e.g., 
acetylcholine and dopamine) contribute to delirium.  
2. Stress Response 
Hypothesis 
Perioperative stress impairs the hypothalamic-pituitary-adrenal 
axis, stimulates the release of cortisol, and alters physiologic 
concentrations of both inflammatory mediators (e.g., cytokines) 
and neurotransmitters that contribute to delirium.  
3. Neuroinflammation 
Hypothesis 
The neuroinflammatory response associated with surgery and 
anesthesia triggers the release of pro-inflammatory mediators 
(e.g., interleukins, prostaglandins, C-reactive protein, and tumor 
necrosis factor) that may interrupt the blood-brain barrier’s 




Surgical patients may present for surgery and anesthesia with 
previously undiagnosed or subclinical Alzheimer’s disease that 
is identified postoperatively.  
5. Cerebral Vascular 
Hypothesis 
Preexisting subclinical cerebral vascular disease/events may 
predispose a subset of patients to delirium.  
6. Oxygen Deprivation 
Hypothesis 
A reduction in cerebral oxidative metabolism (i.e., the 
physiologic process by which oxygen is used to produce the 
energy substrate adenosine triphosphate from carbohydrates) 
contributes to delirium.  
7. Cellular Signaling 
Hypothesis  
Alterations in intraneuronal signal transduction mechanisms 
contribute to delirium.  
 
The predominant hypothesis discussed throughout the literature is the neurotransmitter 
hypothesis. This is likely because several other hypotheses ultimately result in alterations in the 
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synthesis, storage, and/or release of neurotransmitters (Mulkey et al., 2019). Nine different 
neurotransmitters are purported to contribute to delirium including: acetylcholine, dopamine, 
GABA, melatonin, tryptophan, serotonin, glutamate, norepinephrine, and epinephrine (Inouye et 
al., 2014). However, the vast majority of experimental and observational evidence focuses on the 
role that acetylcholine and dopamine play in the pathophysiology of delirium (Inouye et al., 
2014). This focus is likely related to the clinical use of anticholinergic and dopaminergic 
medications in the perioperative and intensive care settings where delirium is often identified 
(Inouye et al., 2014).  
Acetylcholine, a combination of acetic acid and choline, is a neurochemical messenger 
responsible for a wide variety of cell-to-cell communications throughout the body (Sam & 
Bordoni, 2020). In the brain, acetylcholine promotes arousal, motivation, attention, and memory 
(Sam & Bordoni, 2020). For this reason, researchers are working to identify specific neurologic 
circuits through which acetylcholine carries out these functions as potential treatment targets for 
altered neurocognitive states (Venkatesan et al., 2020). Simply stated, a decrease in acetylcholine 
concentrations in the brain and central nervous system is thought to be a primary contributory 
mechanism of delirium (Plaschke et al., 2007). For this reason, the American Geriatrics Society 
(2015) recommends avoiding anticholinergic medications (e.g., scopolamine and amitriptyline), 
when possible, in older surgical patients.  
Dopamine, the precursor to norepinephrine in the catecholamine synthesis pathway, is 
another neurochemical messenger involved with an array of physiologic functions. In the brain, 
dopamine plays a key role in facilitating cognition and behavior. Dopamine levels can impact 
mood, attention, memory, learning, motor function, and hormone release. Increased levels of 
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dopamine in the brain are thought to play a major contributory role in states of hyperactive 
delirium (i.e., agitation, combativeness, and hallucinations / delusions) (Mulkey et al., 2018). 
Electroencephalography 
Electroencephalography (EEG) changes, specifically frequency-band power ratios (e.g., 
theta/alpha ratio), associated with altered neurotransmitter concentrations are reportedly some of 
the most dependable delirium biomarkers (Maldonado, 2008). EEG is also useful in 
differentiating delirium caused by an organic etiology versus a functional or psychiatric disorder 
(Inouye et al., 2014). Provider administered questionnaire-based neurocognitive assessments 
(e.g., MoCA, Mini-Cog©, and CAM) do not differentiate this level of detail related to the causal 
etiology of altered neurocognitive states. EEG-based assessment of cognitive function and the 
ability to differentiate patients according to their baseline neurocognitive state may aid to 
identify and stratify older surgical patients based on their risk for developing POD, inform 
anesthesia care plans, and develop perioperative brain health protocols to mitigate postoperative 
neurocognitive disorders.  
In 1890, Adolf Beck reported the use of electrodes to note changes in the brain’s 
electrical activity in response to a stimulus (Coenen & Zayachkivska, 2013). In 1924, Hans 
Berger captured and graphed these changes to produce an EEG (Gibbs, F., A., Gibbs, & Lennox, 
1937). In 1937, Gibbs et al. reported that anesthetic medications caused predictable and 
consistent changes in the amplitude and frequency of the EEG waveform. As the science evolved 
and demonstrated correlation between EEG changes and a patient’s state of consciousness, the 
concept of EEG-guided anesthesia emerged (Martin, Faulconer, & Bickford, 1959). However, 
EEG-guided anesthesia has not become routine because few anesthesia providers are trained in 
the complex skill of raw EEG analysis and interpretation (Purdon et al., 2015).  
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As technology advances and becomes more user-friendly, new POC EEG assessment 
modalities may offer clinicians the ability to rapidly perform and interpret EEG-based 
neurocognitive assessments. The ability to do so could be important in advancing the state of the 
science of POD since some have argued, hypothetically, that postoperative neurocognitive 
decline is a post hoc, ergo propter hoc (i.e., after this, therefore because of this) misattribution 
fallacy (Avidan & Evers, 2016). That is to say that some researchers believe that postoperative 
neurocognitive decline is the identification of preexisting, undiagnosed decline in a patient’s 
neurocognitive trajectory (Avidan & Evers, 2016). Figure 4 illustrates Avidan and Evers’ (2016) 
hypothetical perioperative neurocognitive trajectory model. 
Figure 4 
 
Hypothetical Perioperative Cognitive Trajectory  
 
 
Note: Image adapted from Avidan and Evers, 2016.  
 
Preexisting, undiagnosed or subclinical cognitive impairment has been identified in a 
significant number of surgical patients when a battery of neuropsychological tests are employed 
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(Silbert et al., 2015). Evered et al. (2011) identified that 20% of 152 patients over the age of 60 
years presenting for hip replacement surgery demonstrated significant preexisting cognitive 
impairment defined as a score two standard deviations below the norm on at least two of seven 
neuropsychological assessments. Silbert et al. (2015) conducted a prospective observational trial 
of 300 patients presenting for hip replacement surgery and 51 nonsurgical patients age 60 years 
or greater and identified preexisting cognitive impairment in 32% of patients when assessed 
using a battery of eight neuropsychological assessments including the: Consortium to Establish a 
Registry in Alzheimer Disease (CERAD) test, Auditory Verbal Learning Test, Trail Making Test 
Parts A and B, Digit Symbol Substitution Test, Controlled Oral Word Association Test, CERAD 
Semantic Fluency Test , and Grooved Pegboard Test. Scott et al. (2018) reported that 51.7% of 
437 patients presented for left heart catheterization with preexisting neurocognitive impairment 
using a battery of both written and computerized assessments including the: CERAD Auditory 
Verbal Learning Test, Trail Making Test Parts A and B, Digit Symbol Substitution Test, 
Controlled Oral Word Association Test, CERAD Semantic Fluency test, and Grooved Pegboard 
test.  
Assessing EEG biomarkers alone or in combination with questionnaire-based cognitive 
assessments may improve both the clinical detection of preexisting cognitive impairment as well 
as the prediction and detection of postoperative neurocognitive alterations (Mulkey et al., 2018). 
Tanabe et al. (2020) reported a significant correlation between high alpha power and increased 
alpha band connectivity on preoperative EEG and the subsequent development of postoperative 
delirium. Additionally, Ha et al. (2020) reported what they believe to be an EEG complexity 
measure that predicts postoperative attention deficits. While useful in clinical research, 
traditional EEG-monitoring modalities are not practical in the routine preoperative anesthetic 
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assessment of older surgical patients related to cost, time, and technical skill limitations (Inouye 
et al., 2014; Mulkey et al., 2018; Mulkey et al., 2019).  
Delirium detection, especially early detection, is critical because prolonged duration of 
delirium is associated with increased treatment difficulty (Mulkey et al., 2019). EEG-based 
delirium assessments can often identify a delirious brain state prior to the presentation of clinical 
signs and symptoms (Mulkey et al., 2019). Mulkey et al. (2019) is evaluating the clinical utility 
of a novel limited lead EEG device, Ceribell, for detecting delirium in ICU patients due the 
limited clinical utility of gold-standard delirium assessment tools used in research (e.g., CAM). 
When CAM-ICU is incorporated into routine clinical practice, less than 50% of ICU patients 
with delirium are diagnosed (Soja et al., 2008). This may be due to the extensive and recurrent 
training required to maintain high inter-rater reliability and the significant staff turnover reported 
among ICU nurses (Milkey et al., 2019). Similar training and staff turnover challenges would 
likely be present in post-surgical units attempting to incorporate CAM for the routine assessment 
of postoperative delirium. For these reasons, Inouye et al. (2014) advocate for further 
investigation into the clinical use of novel EEG devices (e.g., quantitative and spectral EEG) as 
they may have clinical utility, but “their performance characteristics need further investigation” 
(p. 917). 
Preoperative anesthesia assessments include a detailed review of cardiovascular and 
respiratory function (e.g. assessing metabolic equivalency to task (METs), auscultating the heart 
and lungs, and reviewing pertinent laboratory values). However, minimal assessment of 
anesthesia’s primary target, the brain, is routinely completed. As previously noted, Crosby et al. 
(2011) stressed this concern: 
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…that we currently make no effort to identify [older patients with a vulnerable brain 
state] preoperatively is an embarrassing state of affairs considering that the brain is a 
principal target of general anesthetic agents, the field of anesthesiology champions 
thorough preoperative evaluation, and perioperative cognitive morbidity in the elderly is 
so common and costly (p. 1267).  
One major barrier to completing a more thorough preoperative neurocognitive assessment is that 
no rapid, easily-administrable, valid, reliable, automatically scored, and cost-efficient assessment 
of neurocognitive function that is void of language, cultural, and education bias is currently 
available to anesthesia providers for routine clinical use.  
EEG-based P300 AEPs as neurobiomarkers might enable anesthesia providers to better 
assess baseline neurocognitive function in older surgical patients prior to surgery and anesthesia 
if the device and process used to conduct these assessments is practical in regards to the skills 
and equipment required to perform the test and interpret the results. Objective assessments, such 
as P300 AEPs, may detect mild or even subsyndromal cognitive impairments that are currently 
missed in a subset of patients by clinically utilized cognitive assessment tools (e.g., MoCA, 
Mini-Cog©, and CAM) as well as perioperatively track the progression of patients’ cognitive 
status relative to their baseline to determine if, and when, postoperative neurocognitive 
alterations occur. 
Novel Point-of-Care EEG Assessment System 
The WAVi MedicalTM system (Boulder, CO) is a patented, novel, noninvasive, FDA-
cleared POC EEG hardware and software application platform designed to rapidly perform EEG-
based neurocognitive assessments (WAVi, 2019). See Appendices D, E, and F. The WAVi 
MedicalTM system is a unique device that utilizes innovative saline moistened fabric electrodes, 
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eSocsTM, to transmit and record the brain’s electrical activity and an integrated artifact detection 
software system that enhances test-retest and inter-rater reliability when conducting POC EEG-
based assessments. The WAVi MedicalTM system has been successfully used to assess baseline 
cognitive function and track changes over time in individuals following traumatic brain injury 
(Grover et al., 2017; Clayton et al., 2020). The system is currently being used as a 
neurocognitive assessment tool in a National Institutes of Health (NIH)-funded chronic pain 
study (National Institutes of Health, 2018). The system is also being utilized to measure onset 
and progression of cognitive decline in preclinical Alzheimer's patients at the University of 
Texas at Dallas (Clinicaltrials.gov, 2018). There is a gap in the anesthesia literature in that the 
potential clinical utility of the WAVi MedicalTM system as a neurocognitive assessment tool has 
never been evaluated in the perioperative setting.  
The WAVi MedicalTM system consists of the following major components: headsets, 
solutions, electronics, accessories, and documentation systems. Table six presents a detailed list 
of the WAVi MedicalTM system components. Three headset sizes (e.g., small, medium, and 
large) are included with the WAVi MedicalTM system to accommodate a wide range of head 
circumferences (WAVi, 2019). The headset is made of a soft double layered closed-cell resin-
based foam that easily flexes to the contour of an individual’s head (Oakley, 2018). Figure 5 
shows the WAVi MedicalTM EEG Headset. Receptacles are located throughout the headset and 
positioned in the locations of a standard 10-20 EEG montage. The standard 10-20 EEG montage 
is depicted in Figure 6. An electrical conduction strip is located within the headset between the 
two layers of foam. Unique to the WAVi MedicalTM system, single-use eSocs (i.e., ~ 1in long x 
0.25in diameter plastic, fabric-covered electrodes) moistened with a 0.9% sodium chloride 
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solution (i.e., normal saline) are inserted into the receptacles just prior to performing an 
assessment. Figure 7 depicts an image of eSocs. 
Table 6 
WAVi MedicalTM System Components  
Headsets Electronics 
- Small headset 
- Medium headset 
- Large headset 
- Laptop computer with WAVi
TM
 desktop software 
- USB mouse 
- Electronic processing unit (EPU) 
- USB mini-B cable for EPU 
- Headphones 
- 3.5mm auxiliary cable for headphones 
Accessories Solutions 
- Portable bag 








TM trays  
- Sizing ribbon 
- Syringes 
- Blunt needles 
- Towels and washcloths 
- Magnetic ear electrodes 
- Alcohol cleaning wipes 
- Diamond bands  
- Hand sanitizer 
- NuPrep® skin prep gel  
- Conduction cream 
- 0.9% sodium chloride saline solution 
Documentation Systems 
- Instruction manual 
- Quick setup and scan guide 












EEG Headset: WAVi MedicalTM System (Boulder, CO) 
 
 
Note: The soft closed-cell resin-based headset used for conducting EEG-based neurocognitive 




Standard 10-20 EEG Montage 
 
 












WAVi MedicalTM System (Boulder, CO) eSocs 
 
 
Note: Three dry eSocs (left) and a tray of 20 saline moistened eSocs (right) used to conduct the 
electrical EEG signal from the participant’s scalp to the WAVi MedicalTM headset. 
 
The use of saline-moistened eSocs eliminates the need for metal electrodes to be secured 
next to the scalp or the need for large amounts of conduction gel to be applied (Oakley, 2018). 
Saline soaked eSocs serve as the conduction mechanism for electrical energy to be transferred 
from the patient’s scalp to the metallic rings located around each receptacle. Figure 8 shows an 
eSoc inside a metallic ring of the WAVi MedicalTM EEG Headset. 
Figure 8 
 
WAVi MedicalTM eSoc Inside the Metallic Ring of a Headset Receptacle  
 
 
Note: An eSoc placed inside the metallic ring of a headset receptacle with the blue end facing the 
adjustment bands on the outside of the headset and the white end pointing inward. 
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These metal rings connect to an electrical conduction strip, embedded within the two layers of 
closed-cell resin-based foam, that conducts the electrical signal to the electrical processing unit 
(EPU).  
The EPU, which amplifies and filters the electrical signal, is connected to the laptop 
computer via a universal serial bus (USB) mini-B cable to capture the electrical signal and 
display the graphed EEG waveforms in the WAVi MedicalTM desktop software application. 
WAVi-based neurocognitive scan assessments are completed in accordance with the WAVi 
Instruction Manual Version 0.9.8.17 (see Appendix E). All investigators performing 
neurocognitive assessments for the data source study, “Perioperative Brain Health” – IRB 
HM20019839, with the WAVi MedicalTM system completed three online competency-based 
training modules: 1) Kit Components and Set Up, 2) Headset Contact, and 3) Running the P300 
Protocol. Figure 9 depicts a screenshot from one of the online competency-based training 
modules.  
Figure 9 
Online Competency-based Training Module 1 
 
Note: A screenshot from WAVi MedicalTM’s first competency-based training module: Kit 




In addition to the online training, one of the data source study’s investigators traveled to WAVi 
MedicalTM, Boulder, CO for in-person training on the device and was approved by the device 
manufacturer to train research assistants. Research assistants successfully completed a two hour 
in-person, proctored, simulated WAVi MedicalTM setup, preparation, and P300 protocol training 
as well as at least two proctored, clinical evaluations of their ability to setup, prepare, and 
administer the P300 protocol with the WAVi MedicalTM device.  
Performing an EEG assessment with the WAVi MedicalTM platform is a four step 
process: 1) equipment set up, 2) participant preparation, 3) donning the headset, 4) performing 
the assessment (WAVi MedicalTM, 2017). To set up the WAVi MedicalTM system, an 
investigator fills one 5cc syringe with 0.9% saline and one 5cc syringe with 
electroencephalogram (EEG) conduction cream (WAVi MedicalTM, 2017). The investigator 
opens one tray of 20 WAViTM eSocs and pours approximately 25ml of normal saline over the 
eSocs in the tray. The WAViTM desktop application is accessed on a secure, password protected 
study laptop (e.g., Dell©, Latitude 3190) in airplane mode (i.e., with WiFi disabled). The 
investigator connects the EPU to the study laptop via a USB mini-B cable and clicks the +New 
Patient button in the WAViTM desktop application.  
The participant is asked to remove all hair accessories (e.g., clips, bobby pins, hair ties, 
barrettes) and earrings from the earlobes (WAVi MedicalTM, 2017). The participant’s earlobes 
are exfoliated using NePrep® skin prep gel, and a paper towel is provided to clean any residual 
NuPrep® off of their earlobes and fingers. The participant’s head circumference is measured 
using a sizing ribbon (i.e., a flexible plastic measuring tape with predefined markings) to identify 
the appropriate size headset (e.g, small, medium, or large) for the participant. The investigator 
places the saline moistened eSocs into the headset receptacles with the blue ends facing the 
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flexible rubber diamond-shaped adjustment bands and the white ends pointing inward to make 
contact with the participant’s scalp.  
Immediately prior to the participant in donning the headset, the investigator places ~0.5cc 
of conduction cream on each of the patient’s earlobes, opens the heart rate variability ear clips, 
and gently closes one clip onto each of the participant’s earlobes. The investigator then assists 
the participant in placing the headset onto the head in a manner similar to wearing a baseball cap. 
The investigator ensures optimal headset placement on the participant's head by centering the 
heart shaped opening at the front of the headset over the participant ’s nasion (i.e., bridge of the 
nose). The heart rate variability ear clips are then connected to the EPU, and the EPU is 
connected to the laptop computer. A pair of soft, cushioned headphones are placed on top of the 
headset over the participant’s ears and connected to the EPU. The headset is then visually 
inspected to ensure that the white tips of the eSocs make contact with the participant’s scalp.  
If poor scalp contact is identified, the investigator augments eSocs with poor contact by 
repositioning the headset, gently brushing a small amount of hair away from any eSOCs with 
poor contact (WAVi MedicalTM, 2017). The investigator then clicks the +Headset Contact button 
in the desktop application and inspects for adequacy of the acquired electrical signal from all 20 
electrode sites. Sites with sufficient scalp contact and adequate electrical signal are highlighted 
as yellow or green in the desktop application, sites with a poor signal that require contact 
adjustment are highlighted red. Figures 10 and 11 show screenshots of the software’s contact 
feedback system. Visual inspection and electrode augmentation steps, such as applying a small 
amount of either saline or conductive cream underneath eSoc sites with a poor signal (i.e., those 
highlighted red), are repeated until an adequate signal is confirmed at all sites (WAVi 




Desktop Application Electrode Contact Assessment Page--Good Contact  
 
 
Note: Electrode sites with sufficient scalp contact and adequate electrical signal are highlighted 




Desktop Application Electrode Contact Assessment Page--Poor Contact  
 
 
Note: Electrode sites with sufficient scalp contact and adequate electrical signal are highlighted 





To perform a neurocognitive assessment, the investigator ensures that the computer 
mouse is located under the participant’s dominant hand and initiates the "WAVi Performance" 
protocol within the desktop application (WAVi MedicalTM, 2017). The WAVi Performance 
protocol consists of a series of 3 EEG-based neurocognitive assessments: 1) a one-minute 
baseline eyes closed raw-wave EEG assessment, 2) a four-minutes eyes closed P300 assessment, 
and 3) a one-minute eyes open tracking assessment. Figure 12 shows an individual participating 
in neurocognitive assessment, and Figure 13 displays a screenshot of the WAVi MedicalTM 
software during a one-minute eyes open tracking protocol. 
Figure 12 
Person Participating in Neurocognitive Assessment  
 
 
The WAVi MedicalTM system is designed to automatically detect and report artifact in the 
EEG signal. Artifact is an erroneous EEG signal derived from extra-neural sources (e.g., patient 
movement). Artifact is indicated by the red and blue coloration on EEG waveforms and as red 
highlighting over respective sites on the 10-20 montage map. Figure 13 illustrates this artifact 




One-minute Baseline Eyes Closed Raw-wave EEG Assessment 
 
 
Note: Artifact is noted as red and blue coloration in FP1 and F8 waveforms (left side of image) 
and red highlighting over the F8 site on the 10-20 EEG montage (right side of image). 
 
One neurocognitive assessment attainable with the WAVi MedicalTM system is the 
previously validated auditory P300 AEPs. To perform the four-minutes eyes closed P300 
assessment using the WAVi MedicalTM system, the investigator explains the auditory P300 Eyes 
Closed test to the participant: "During the test you will hear two different audible tones, a 
common low-pitched tone and a rare high-pitched tone. When you hear the rare, high-pitched 
tone, click the mouse button." The investigator provides the participant with a brief, < 30 second 
practice session and then selects the "P300 Eyes Closed Protocol" within the WAVi MedicalTM 
desktop application. During the test, the participant is presented with 200 baseline (i.e., low-
pitched) tones and 40 oddball (i.e., high-pitched) tones over four minutes. Following the test, 
EEG data is reviewed by the investigator for signal quality. If data quality is acceptable, the test 
is complete. If data quality is unacceptable, the test is repeated one additional time. 
P300 event-related evoked response tests can be used as a neurophysiological marker for 
even mild neurocognitive disorders (Levada et al., 2016). These assessments utilize an oddball 
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paradigm to evaluate the brain’s response to a novel stimulus (van Dinteren et al., 2014). The 
term “oddball paradigm” refers to the presentation of a randomly interspersed (i.e., oddball) 
auditory stimulus (e.g., a high-pitched tone) presented within a series of background baseline 
auditory stimuli (e.g., low-pitched tones) (van Dinteren et al., 2014). Healthy brains process and 
respond to the oddball stimulus, or high-pitched tone, differently than unhealthy brains. When a 
healthy brain is presented with an oddball stimulus, the amplitude (i.e., size) of graphed 
waveforms of the brain’s electrical activity are expected to be larger than those produced by an 
unhealthy brain, and the latency (i.e., a graphed representation of the time required for signal 
conduction among brain cells) is expected to be shorter.  
Brain power and cognitive resources are associated with signal amplitude (i.e., power in 
microvolts) on EEG (van Dinteren et al., 2014). Brain speed and efficiency are associated with 
signal latency (i.e., delay in milliseconds) on EEG (van Dinteren et al., 2014). The graphed 
waveform changes identified on EEG following the presentation of an oddball stimulus often 
present approximately 300 milliseconds after the stimulus is presented. For this reason, these 
waveforms are referred to as P300 waveforms and the assessment as a P300 auditory evoked 
potential. However, the waveform change may present with varying degrees of latency 200-500 
milliseconds after an auditory stimulus is presented depending on an individual’s age, gender, 
and brain health (Sur & Sinha, 2009; Uvais et al., 2018). Additionally, the amplitude (i.e., size) 
of the P300 waveform varies with cognitive resources (Levada et al., 2016). Such variations in 
amplitude and latency of the P300 waveform are associated with alterations in brain health 






The P300 waveform is a large positive waveform extracted from the EEG signal in 
response to an oddball paradigm during an auditory-evoked response test (van Dinteren et al., 
2014). An auditory evoked response oddball paradigm consists of the presentation of a randomly 
interspersed oddball target auditory stimulus (e.g., high-pitched tone) within a series of common 
background baseline auditory stimuli (e.g., low-pitched tones). Even though the P300 waveform 
represents a positive change in amplitude from baseline, the waveform is classically graphed as a 
downward deflection from baseline. See Figures 14-17.  
Figure 14 
Four-minute Eyes Closed P300 Assessment 
 
Note: The black vertical line overtop the EEG waves (left side of image) denotes the presentation 
of a common auditory stimulus. The redline overtop the EEG waves denotes the presentation of 
an oddball auditory stimulus. The green line overtop the EEG waves denotes the participant’s 
physical response (i.e., mouse button click). Artifact is identified as red and blue coloration of 









Illustrated Event Related Response Test, Baseline Waveform, & P300 Waveform 
 
 
Note: An illustrated comparison of the differences observed in the P300 waveform  
following the presentation of an oddball stimulus versus a background stimulus. Image adapted 




Average P300 Waveform Captured at a Single Site (Pz) 
 
 





Average P300 Waveforms Captured at All 10-20 EEG Montage Sites 
 
Note: FP1 and FP8 do not display waveforms in this image because the software’s auto artifact 
detection system identified an insufficient number of adequate P300 waveforms at the FP1 (8/40) 
and F8 (5/40) locations. 
 
P300 Changes Associated with Altered Neurocognitive States 
Changes in the amplitude and latency of the P300 waveform are associated with altered 
neurocognitive states (Polich, 2004; Sur & Sinha, 2009; Clayton et al. 2020). Specifically, 
reduced P300 amplitude and prolonged P300 latency have both been associated with 
neurobiological vulnerabilities including mild cognitive impairment, Alzheimer’s disease, and 
dementia (Egerházi et al., 2008; Hedges et al., 2016; Medvidovic et al., 2013; Uvais et al., 2018; 
Yilmaz et al., 2017). 
Yener et al. (2013) demonstrated that event-related evoked response tests can be used to 
detect mild cognitive impairment. Krishnamurthy et al., (2019) reported that auditory evoked 
P300 tests can be used to identify subclinical cognitive impairment in patients with chronic 
obstructive pulmonary disease (COPD). Yilmaz et al. (2017) demonstrated that auditory evoked 
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P300 tests provide a diagnostic tool for mild cognitive impairment in patients with Parkinson’s 
disease. Patients with mild cognitive impairment demonstrated prolonged P300 latency and often 
(i.e., 35% of the time) a total loss of the P300 amplitude relative to patients without mild 
cognitive impairment (Yilmaz et al., 2017). Egerházi et al., (2008) reported that P300 latency 
was significantly prolonged in patients with mild cognitive impairment with cerebral atrophy as 
well as in patients with both vascular and Alzheimer’s dementia.  
Parra et al. (2012) reported that P300 is a “very useful method for the preclinical 
assessment of [Alzheimer’s disease], particularly in populations with low socioeconomic and 
educational levels.” Meta-analysis and meta-regression of 646 participants from twenty P300 
studies identified a reduced P300 amplitude in participants with Alzheimer’s disease versus 
healthy controls (Hedges et al., 2016). Additionally, recent meta-analyses identified that P300 
latencies were prolonged in patients with mild cognitive impairment, relative to healthy controls, 
and prolonged in patients with Alzheimer’s disease relative to patients with mild cognitive 
impairment (Gu & Zhang, 2017; Howe et al., 2014; Jiang et al., 2015; Morrison et al., 2018). 
This data indicates that auditory evoked P300 tests may have clinical utility as an identification 
tool, differential biomarker, and possibly predictive metric for the progression of neurocognitive 
impairments (Gu & Zhang, 2017; Howe et al., 2014; Jiang et al., 2015; Morrison et al., 2018).   
Montreal Cognitive Assessment (MoCA) 
MoCA version 8.1 (see Appendix A) is considered to be the gold standard rapid 
screening tool for identifying mild cognitive impairment (Nasreddine et al., 2005). MoCA is a 
single page assessment instrument used to evaluate a participant’s performance on a battery of 
neurocognitive tests. The assessment takes approximately 15 minutes to administer. The exact 
duration of the assessment depends on how long it takes a participant to complete each test. The 
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neurocognitive tests included in MoCA are: three visuospatial drawing tests, one animal naming 
test, one word list memory test, three attention related tests (e.g., digits, letters, and subtraction), 
two language tests, one abstraction test, one delayed recall test, and one orientation test. During 
the assessment, the administrator remains present with the participant to record and interpret the 
results of each test in real time. If the participant completes a given test without difficulty, they 
receive a point value for that test. Point values for each test range from one to six. The 
participant’s final MoCA score is the summation of all individual test scores. The final MoCA 
score ranges from 0-30 with higher scores indicating a higher level of cognitive function.  
A MoCA score between 26-30 indicates normal cognitive function (Nasreddine et al., 
2005). A MoCA score between 18-25 indicates mild cognitive impairment. This range is 
classified as a MoCA severity level one. A MoCA score 10-17 indicates moderate cognitive 
impairment. This range is classified as a MoCA severity level two. A MoCA score below 10 
indicates severe cognitive impairment. This range is classified as a MoCA severity level three. 
Styra et al. (2019) reported that MoCA scores ≤ 15 are predictive of POD. P300 waveform 
deformities (e.g., prolonged latency and decreased amplitude) reportedly correlate with MoCA in 
patients with idiopathic inflammatory-demyelinating diseases (Zeng, et al., 2017). However, no 
relationship has been established between P300 and MoCA in the perioperative setting.  
Nasreddine et al. (2005) reported a 90% sensitivity and 100% specificity for MoCA to 
diagnose mild cognitive impairment in older persons in the research setting when evaluating 
Caucasian older adults. However, Berger et al. (2018) reported that there is insufficient data to 
report sensitivity and specificity for MoCA in the perioperative setting and that MoCA has an 
inherent education bias. Rossetti et al. (2017) identified that several components of the MoCA 
and previously established cut-off points for cognitive impairment are not well suited for African 
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Americans. In a sample of over 1,000 community-dwelling African Americans with an average 
age of 49 years and no subjective cognitive complaints, the mean MoCA score was 22 (Rossetti 
et al., 2017). In this sample, 72% of participants were unable to complete the cube drawing task, 
66% of participants recalled fewer than 4/5 delayed free recall words, 63% were unable to 
complete the sentence repetition task, and 45% failed the abstraction portion of the assessment 
(Rossetti et al., 2017). These factors all present challenges for the use of MoCA as a routine 
clinical preoperative neurocognitive screening tool as MoCA may underestimate neurocognitive 
function in African American patients (i.e., MoCA scores may be lower for African Americans 
than for Caucasians with an equivalent level of cognitive function). 
Mini-Cog©  
 Mini-Cog© (see Appendix B) is a brief neurocognitive screening tool with a two-part 
empirical scoring algorithm: a 3-word recall and a clock drawing test (Borson et al., 2003). The 
Mini-Cog© is administered in approximately three minutes and is used to detect cognitive 
impairment in older adults. Administration of the Mini-Cog© is a simple four step process:  
1) Gain the patient’s attention by stating “What we’re going to do next will take some 
concentration. Ready?” 
2) Initiate the 3-word recall task by saying “I am going to say three words that I want you 
to remember now and later. The words are banana, sunrise, chair.” 
3) Provide a sheet of paper with a circle already drawn for the patient (See Appendix B) 
and ask the participant to “Please draw a clock in the circle…put all the numbers in the 
circle.” After numbers have been placed in the clock, say “Now set the hand to show ten 
past eleven.” 
4) Say “What were the three words I asked you to remember?”  
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The Mini-Cog© is scored on a scale of 0-5. One point is awarded for each of the three 
words that the participant recalls. Two points are awarded for a normal clock, and no points are 
awarded for an abnormal clock. A normal clock presents with all numbers (1-12) placed in the 
correct order and direction, one hand pointing to the number 11 and one hand pointing to the 
number two. A score ≥ 3 signifies a reduced probability of dementia but does not exclude 
cognitive impairment (Borson, 2021). Mini-Cog© is a validated screening tool for both dementia 
and mild cognitive impairment in older participants (Borson et al., 2003; Steenland et al., 2008). 
However, this simple assessment tool provides only a rough estimate of gross cognitive 
dysfunction. Mini-Cog© interpretation guidelines state “[a] total score of 3, 4, or 5 indicates 
lower likelihood of dementia but does not rule out some degree of cognitive impairment. The 
Mini-Cog© is not a diagnostic test for Alzheimer’s disease or any other dementia or cause of 
cognitive impairment. Diagnosis of brain disorders that cause cognitive impairment requires a 
medical examination and additional examinations” (Borson, 2021). 
Confusion Assessment Method (CAM)  
CAM is a validated tool used by non-psychiatric providers (e.g., bedside nurses) to screen 
patients for POD by assessing for: acute onset, inattention, disorganized thinking, altered 
consciousness, disorientation, memory impairment, perceptual disturbances, psychomotor 
retardation, and altered sleep-wake cycles (Inouye, 2003). Inouye (2003) recommends that CAM 
assessments be based upon a standardized interview between the participant and the investigator. 
Inouye (2003) suggests the administration of Mini-Cog© be used as the standardized interview. 
CAM is considered to be the gold standard screening tool for delirium identification (Inouye, 
2003). CAM has been used for delirium screening in over 250 studies and reportedly has a 94-
100% sensitivity and 90-95% specificity for identifying delirium in the research setting (Inouye, 
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2003). However, in routine clinical practice, less than 50% of ICU patients with delirium are 
identified by CAM (Soja et al., 2008). This may be due to the extensive and recurrent training 
required to maintain high inter-rater reliability and the significant staff turnover reported among 
ICU nurses (Milkey et al., 2019). Similar limitations could be expected if routine postoperative 
CAM assessments were performed on postsurgical recovery units.  
Chapter Summary 
Perioperative neurocognitive disorders are a major brain health related concern for older 
surgical patients (American Society of Anesthesiologists, 2019; Berger et al., 2018; Mahanna-
Gabrielli et al., 2019). Some researchers believe these disorders to be the result of 
neurobiological alterations sustained from surgery and anesthesia, yet others believe them to be a 
post hoc, ergo propter hoc misattribution fallacy (Avidan & Evers, 2016; Berger et al., 2018; 
Mahanna-Gabrielli et al., 2019; Jin et al., 2020). A decade after Crosby et al. (2011) lamented 
“… that we currently make no effort to identify [older patients with a vulnerable brain state] 
preoperatively…” anesthesia providers are beginning to incorporate questionnaire-based 
neurocognitive assessments into the preanesthetic assessment at some academic medical centers 
(p. 1267; Mahanna-Gabrielli et al., 2019; Decker et al., 2020). However, none of these tools are 
routinely used for perioperative neurocognitive assessment due to validity, reliability, and 
practicality concerns (Berger, et al., 2018).  
POD, the first acute event of neurocognitive impairment following surgery and 
anesthesia, is the most prevalent complication experienced by older adult patients (American 
Geriatrics Society, 2015; American Society of Anesthesiologists, 2019). POD distresses patients, 
their loved ones, and care providers, and is associated with inferior functional recovery and 
increased healthcare spending (Hernandez et al., 2017; Hshieh et al., 2017; Inouye et al., 2014; 
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Zywiel et al., 2015). Baseline cognitive function is a strong, independent predictor for POD in 
older surgical patients, and POD is believed to be preventable in up to 40% of patients (Culley et 
al., 2017; Siddiqi et al., 2016). Perioperative patient outcomes may be enhanced by improving 
baseline neurocognitive assessments in order to better identify preexisting neurocognitive 
impairment and risk-stratify patients. EEG-based auditory evoked P300 tests may have clinical 
utility as an identification tool, differential biomarker, and possibly predictive metric for the 
progression of perioperative neurocognitive impairments (Gu & Zhang, 2017; Howe et al., 2014; 
Jiang et al., 2015; Morrison et al., 2018). 
Over 50% of patients who experience POD present with signs of delirium on 
postoperative day one (Iamaroon et al., 2020; Lin et al., 2016). The most common presentation 
of delirium, the hypoactive form, is more challenging to identify in clinical practice and often 
goes undiagnosed (Collins, 2010; Hosker & Ward, 2017). When gold-standard delirium 
assessment tools (e.g., CAM) are incorporated into routine clinical practice, less than 50% of 
patients with delirium are diagnosed (Soja et al., 2008). Early delirium detection is critical 
because prolonged duration of delirium is associated with increased treatment difficulty (Mulkey 
et al., 2019). EEG-based neurocognitive assessments can reportedly identify subsyndromal 
delirium (i.e., neurocognitive changes that portend delirium) prior to the presentation of clinical 
signs and symptoms (Mulkey et al., 2019)  
However, traditional EEG assessment modalities are not easily incorporated in routine 
clinical practice (Inouye et al., 2014; Mulkey et al., 2018; Mulkey et al., 2019). The WAVi 
MedicalTM system is an FDA-cleared POC EEG hardware and software system designed to 
rapidly perform EEG-based P300 AEP neurocognitive assessments (WAVi, 2019). 
Neurobiomarkers obtainable with this device may have clinical utility for identifying, predicting, 
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and tracking perioperative neurocognitive disorders. However, the utility of the WAVi 





























Chapter 3: Theoretical Framework 
 “The secret of quality is love.” -Avedis Donabedian 
 
Chapter Overview 
Chapter three presents this study’s guiding theoretical framework, Donabedian’s 
Theoretical Model for Evaluating the Quality of Medical Care. The chapter begins with a brief 
overview of the origin and history of Donabedian’s model. The suitability of the model for this 
study is discussed. Studies applying and validating the Donabedian model in the perioperative 
setting are identified.  
Introduction 
 
Over 50% of surgical procedures performed in the United States (U.S.) are performed on 
patients over the age of 65 years (Yang et al., 2011). A significant number of these patients may 
subsequently develop postoperative delirium (POD). POD, a state of disorganized thinking and 
inattention, complicates the recovery process and is associated with increased length of 
hospitalization, increased morbidity and mortality, progression to delayed or incomplete 
neurocognitive recovery, and the subsequent development of dementia (Saczynski et al., 2012; 
Koster et al., 2012;  Hshieh et al., 2017; Sprung et al., 2017; Aranake-Chrisinger & Avidan, 
2017). The American Society of Anesthesiologists’ Perioperative Brain Health Initiative 
advocates for research aimed at discovering novel POD identification, mitigation, and prevention 
strategies (American Society of Anesthesiologists, 2019). No rapid, reliable, practical, sensitive 
and specific assessment of neurocognitive function currently exists to preoperatively identify at-
risk patients, recognize POD in the early postoperative period, or track POD in older surgical 
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patients. This study is designed to analyze EEG-based neurocognitive assessment data captured 
in the perioperative setting with an innovative POC EEG hardware and software system, WAVi 
MedicalTM to evaluate the potential clinical utility of neurobiomarkers obtained with the device.  
These neurobiomarkers may one day be used to guide the clinical care of older surgical patients 
and reduce the incidence and/or severity of perioperative neurocognitive disorders (e.g., POD).  
The study was guided by Donabedian’s Theoretical Model for Evaluating the Quality of 
Medical Care (Donabedian, 2005). Donabedian’s care model is the most commonly used 
theoretical framework for evaluating the quality of health care services (Ayanian and Markel, 
2016). Donabedian first published his seminal work in The Milbank Quarterly, a 
multidisciplinary journal of population health and health policy, in June 1966 (Berwick & Fox, 
2016). The paper was reprinted verbatim in the same journal in 2005 (Berwick & Fox, 2016). 
Donabedian (2005) put forth three concepts (structure, process, and outcome) as guiding 
principles for quality improvement. These concepts now serve as the constructs of Donabedian’s 
theoretical model. The three key domains of Donabedian’s quality improvement model are 
shown in figure 18.  
Figure 18 
 




Donabedian’s (1966) theoretical model for evaluating the quality of medical care was a good fit 
for this study because it is descriptive, explanatory, accurate, practical, simple, consistent, and 




Descriptive & Explanatory  
Goes and Simon (2012) state that a theory should explain the “Who? What? When? 
Where? How? [and] Why? about a situation or phenomenon” (p. 2). Donabedian’s (2005) model  
explains all six questions in regards to this study. Three of these questions (i.e., Who?—older 
surgical patients When?—perioperative period Where?—PACE and post-surgical follow-up) are 
addressed within the construct of structure. What—method of neurocognitive assessment—P300 
versus MoCA is addressed by the construct process. Why— to identify novel neurocognitive 
assessment tools and biomarkers for predicting, identifying, and tracking perioperative brain 
health in older surgical patients—can be categorized under the construct outcome.  
Accurate 
Accuracy can be evaluated by “investigating what a variety of experts say regarding the 
theory” (Goes and Simon, 2012, p. 2). Donabedian’s (2005) model has been applied, tested, 
retested and referenced by researchers from a variety of disciplines for over fifty years (Berwick 
& Fox, 2016). Within that time frame the model’s creator authored four books on quality 
assessment in medical care including: 1) The Definition of Quality and Approaches to Its 
Assessment, 2) The Criteria and Standards of Quality, 3) The Methods and Findings of Quality 
Assessment and Monitoring: An Illustrated Analysis, and 4) An Introduction to Quality 
Assurance in Health Care (Berwick & Fox, 2016).  
Practical 
Multiple real-world applications of Donabedian’s (2005) model are identifiable in the 
literature. At least six studies incorporated the model to guide perioperative research. Rose et al. 
(2019) applied the model to guide an integrative review of the literature to identify best practices 
for postoperative patient handoff. Specifically, the authors used Donabedian’s model to organize 
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and synthesize seventeen articles on information transfer during patient handoff from surgical 
and anesthesia teams to the postoperative care unit (PACU) teams. Figure 19 shows Rose et al.’s 
(2019) use of the model.  
Figure 19 
Patient Handoff Structures, Processes, & Outcomes Based on Donabedian’s Model 
 
Note: Image adapted from Rose et al. (2019). 
 
Jeffcott et al. (2009) and Gardener et al. (2014) also employed Donabedian’s model to evaluate 
quality of care of patient handoff and other nursing services.  
Centurion et al. (2018) applied the model to identify the minimum standard of care when 
performing surgery with limited resources following natural disasters in low- and middle-income 
countries. The authors identify that Medécins Sans Frontières (MSF) (i.e., Doctors Without 
Borders) has been providing surgical care services in low- and middle-income countries for 45 
years. Over this time, the organization has utilized Donabedian’s model to measure the quality of 
these services in various locations around the globe. As an example, MSF evaluates human 
resources, infrastructure (e.g., water and electricity supply), biomedical devices, and the supply 
of medications using the structural component of Donabedian’s model (Centurion et al., 2018).   
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Moore et al. (2015) validated the model for assessing quality of care improvement in 
trauma care services in a multicenter retrospective cohort study. Prior to Moore et al.’s (2015) 
study that statistically evaluated correlation between process and outcomes, Donabedian’s model 
had already been widely adopted by trauma care providers to guide quality improvement 
projects. The authors identified that trauma centers with appropriate structures tend to have 
strong clinical processes that positively impact patient outcomes (Moore et al., 2015).  
Tsai et al. (2013) used Donabedian’s model to guide their investigation of the 
readmission rates of surgical patients. The authors incorporated Donabedian’s structure, process, 
and outcome components of quality of care to investigate 30-day readmission rates of 479,471 
Medicare patients from 3,004 different hospitals following a variety of surgical procedures 
including: coronary artery bypass graft (CABG), pulmonary lobectomy, endovascular abdominal 
aortic aneurysm repair (EVAR), open abdominal aortic aneurysm repair (AAA), colectomy, and 
hip replacement.  
Birkmeyer et al. (2004) adopted the Donabedian model to evaluate quality of surgical 
care services. The authors noted that hospitals are increasingly under pressure to evaluate and 
demonstrate quality of care as it becomes increasingly apparent that patient outcomes vary 
nationally by surgeon and hospital. Noting the wide variation of quality improvement metrics 
used in prior studies, the authors sought to report on the potential advantages and disadvantages 
of each after classifying metrics as either structure, process, or outcome in an effort to identify a 
focus for future investigation. Figure 20 depicts an example of how these authors incorporated 
the model.  
Hannan et al. (2001) employed the model to guide a retrospective cohort investigation of 




Example of Structures, Processes, & Outcomes of Surgical Care  
 
Note: Image adapted from Birkmeyer et al. (2004). 
 
noted variation in practice patterns and patient outcomes, the authors sought to identify which, if 
any, processes led to superior inpatient outcomes. The authors identified that when a 
combination of processes (e.g., eversion endarterectomy, protamine, or shunts) were utilized, 
fewer patients had adverse outcomes (OR=0.42, P=0.006).  
Simple 
Donabedian’s (2005) unidirectional model is constructed of three simple concepts: 
structure, process, and outcome. All three constructs are capable of influencing quality of care. 
For this study, structure remained constant, and alternative processes (i.e., neurocognitive 
assessment methods) were evaluated to determine if P300 metrics potentially predict, identify, 






Both internal and external consistency of Donabedian’s (2005) model have been 
considered. Internal consistency refers to the inherent logical nature of a theory, and external 
consistency references a given theory in relation to other theories. Donabedian’s (2005) model is 
logical in the context of this study. Within a defined and relatively consistent structure, changing 
a clinical process could logically affect an outcome. Moore et al. (2015) validated the external 
consistency of the Donabedian model for trauma care. The authors demonstrated statistically 
significant correlation between a process (e.g., conformity to 15 implemented quality 
improvement metrics) and two outcomes (e.g., length of stay (r = - 0.27) and readmission (r = - 
0.33)).  
Acute 
Goes and Simon (2012) describe an acute theory as one that is able “to provide insight 
into an otherwise complex problem” (p. 3). Perioperative neurocognitive disorders are quite a 
complex problem. The causative etiology of POD is unknown and likely multifactorial (Wu et 
al., 2019). What is known is that baseline cognitive function is a strong, independent predictor 
for POD in older surgical patients (Adegowa et al., 2018). However, no rapid, reliable, practical, 
and highly sensitive and specific neurocognitive assessment tool is currently available to 
anesthesia providers for routine clinical care.  
As previously mentioned, Crosby et al. (2011) lamented this problem:  
…that we currently make no effort to identify [older patients with a vulnerable brain 
state] preoperatively is an embarrassing state of affairs considering that the brain is a 
principal target of general anesthetic agents, the field of anesthesiology champions 
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thorough preoperative evaluation, and perioperative cognitive morbidity in the elderly is 
so common and costly (p. 1267).   
To address this gap, this study employed Donabedian’s (2005) model.  
Application of Donabedian’s Quality of Care Model 
Donabedian’s (2005) model clearly identifies and operationalizes three categories for 
consideration when seeking to improve patient outcomes in health care research. Structure refers 
to the physical and organizational characteristics where healthcare occurs. In this study, the 
structure referenced the perioperative setting (i.e. specifically, the preoperative assessment, 
communication, and education (PACE) clinic and the post anesthesia care unit (PACU)). Process 
refers to the manner in which a system or procedure works to provide a desired outcome, and 
outcome refers to the impact an intervention has on patients. In this study, the process-outcome 
relationship being investigated was the utilization of EEG-based P300 neurocognitive metrics 
versus best medical practice (e.g., MoCA) to identify and track perioperative neurocognitive 
states in older surgical patients. See Figure 21.  
Figure 21 
 







Specific Aims & Hypotheses 
 
Specific Aim #1: Evaluate the ability of participants’ preoperative baseline P300 latency 
(i.e., brain speed) and P300 amplitude (i.e., brain power) to predict participants’ cognitive 
function. This study used regression to understand whether auditory P300 amplitude (in 
microvolts) and auditory P300 latency (in milliseconds) predict cognitive function among 
older surgical patients as assessed by MoCA. Each variable was considered 
independently as they measure two separate constructs of neurocognition, namely 
cognitive resources (i.e., brain power) and cognitive efficiency (i.e., brain speed).  
Hypothesis #1: Lower P300 amplitude will be predictive of lower MoCA scores.  
Hypothesis #2: Higher P300 latency will be predictive of lower MoCA scores.  
Specific Aim #2: Evaluate for group differences in pre- to postoperative P300 AEP 
change scores (i.e., amplitude (in microvolts) and latency (in milliseconds)) between 
participants who received two or more potentially neuroprotective multimodal anesthetic 
adjunct medications (i.e., magnesium, lidocaine, and/or ketamine) versus those who did 
not.  
Hypothesis #3: Participants who received two or more potentially neuroprotective 
multimodal anesthetic agents will demonstrate a larger positive change in their 
P300 amplitude, measured as a pre- to postoperative change score in microvolts.  
Hypothesis #4: Participants who received two or more potentially neuroprotective 
multimodal anesthetic agents will demonstrate a smaller degree of prolongation in 
their P300 latency relative to their baseline, measured as a pre- to postoperative 







 Each year, 50% of surgeries in the U.S. are performed on patients over the age of 65 
years (Yang et al., 2011). The most common complication experienced by these patients is POD. 
POD is a state of confusion and inattention that complicates the recovery process, increases 
hospital length of stay, increases patients’ morbidity and mortality risk, and escalates health care 
costs (Saczynski et al., 2012; Koster et al., 2012;  Hshieh et al., 2017; Sprung et al., 
2017; Aranake-Chrisinger & Avidan, 2017). Improved neurocognitive assessment tools may 
offer anesthesia providers more detailed information on the state of a patient’s brain throughout 
the perioperative period. Such information could guide the development of a perioperative brain 
health protocol to reduce the incidence and severity of POD in older surgical patients. 
This study, guided by Donabedian’s Theoretical Model for Evaluating the Quality of 
Medical Care, was designed to analyze the utility of EEG-based neurocognitive assessment data 
to perioperatively identify and track neurocognition in older surgical patients. Donabedian’s 
model was appropriate for this study because the model is descriptive, explanatory, accurate, 
practical, simple, consistent, and acute in identifying links between practice processes and 
patient outcomes in the perioperative setting (Birkmeyer et al., 2004; Centurion et al., 2018; 














Chapter 4: Methodology 
Chapter Overview 
The purpose of this study was to explore baseline and postoperative neurocognitive 
characteristics that may help to establish novel predictive and trend metrics for perioperative 
neurocognitive assessment in older surgical patients. As a proof-of-concept study, this research 
primarily sought to identify associations that may be useful in generating hypotheses to guide 
future research. This study was largely a proof of concept study, due to the small sample size of 
records available from the data source study, accepting the impact of sample size on statistical 
conclusion validity. The study evaluated the potential for P300 AEPs to recognize and track 
perioperative neurocognitive alterations in older surgical patients. The identification, 
organization, and analysis of study variables was guided by the three constructs of Donabedian’s 
Theoretical Model for Evaluating the Quality of Medical Care: structure, process, and outcome. 
Chapter four presents the study’s methodology including: research design, data source, sampling 
strategy, and study variables. This chapter describes the study’s data management and analysis 
plans in detail, and concludes with a discussion of assumptions, limitations, and the study’s 
significance.  
Research Design 
To evaluate the potential utility of P300 AEPs for assessing and tracking perioperative 
brain health in older surgical patients, the following methodology was used. The study employed 
a non-randomized, non-experimental, ex post facto secondary data analysis design to 1) 
retrospectively compare participants’ P300 AEPs to MoCA scores before surgery and anesthesia 
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and 2) evaluate for mean group differences in pre- and postoperative change scores between 
participants who received two or more potentially neuroprotective multimodal anesthetic agents 
and those who did not. Secondary data analyses explore research questions by using an existing 
data set (Hulley et al., 2013).  Secondary data sources may include electronic medical records, 
administrative databases, or existing research studies (Hulley et al., 2013). In retrospective 
studies, investigators begin with a dependent variable and look backward to determine whether 
or not an association exists between the dependent variable and one or more independent 
variables (Polit & Beck, 2017). Retrospective designs can be used to identify potentially 
predictive factors for an outcome (Polit & Beck, 2017).  
Aims & Hypotheses  
This study evaluated two specific aims. The first study aim was to evaluate the ability of 
participants’ preoperative baseline P300 latency and amplitude to predict participants’ cognitive 
function as assessed by MoCA. The second study aim was to evaluate for mean group 
differences in pre- to postoperative P300 AEP change scores between participants who received 
two or more potentially neuroprotective multimodal anesthetic adjunct medications (e.g., 
lidocaine, ketamine, and magnesium) versus those who did not. Table seven delineates the study 
purpose, aims, and hypotheses.  
Data Source 
Data for this study was extracted from the VCU/VCUHS REDCap® database: 
“Perioperative Brian Health” – PID 22988. Data in this database was collected using a 
longitudinal, repeated measures design to conduct a prospective observational trial with a set of 





Study Purpose, Aims, and Hypotheses  
Purpose Aims Hypotheses 




may help to establish 
novel predictive and 
trend metrics for 
perioperative 
neurocognitive 
assessment in older 
surgical patients  
Aim1: Evaluate the ability 
of participants’ preoperative 
baseline P300 latency and 




Aim2: Evaluate for group 
differences in pre- to 
postoperative P300 AEP 
change scores between 
participants who received 
two or more potentially 
neuroprotective multimodal 
anesthetic adjunct 
medications versus those 
who did not. 
H1: Lower P300 amplitude will be 
predictive of lower MoCA scores.  
 
H2: Higher P300 latency will be 
predictive of lower MoCA scores.  
 
H3: Participants who received two or 
more potentially neuroprotective 
multimodal anesthetic agents will 
demonstrate a larger positive change 
in their P300 amplitude, measured as 
a pre- to postoperative change score 
in microvolts. 
 
H4: Participants who received two or 
more potentially neuroprotective 
multimodal anesthetic agents will 
demonstrate a smaller degree of 
prolongation in their P300 latency 
relative to their baseline, measured as 
a pre- to postoperative change score 









The “Perioperative Brian Health” –  PID 22988, database is being created as part of an 
ongoing interdisciplinary perioperative brain health study with multiple research aims that are 
separate from this study. The database currently contains perioperative neurocognitive 
assessment records for 20 participants. Not all participants’ records in the database met the 
eligibility criteria for this study. The “test” or intervention refers to participants’ scheduled 
elective surgery and anesthetic. Preoperative baseline neurocognitive assessments were 
completed using the WAVi MedicalTM software and hardware system and MoCA. Figure one 
depicts the WAVi MedicalTM neurocognitive assessment platform. Appendix A presents the 
MoCA.  
WAVi MedicalTM scans were conducted and interpreted by trained research team 
members. WAVi MedicalTM scans were performed as participants attempted an event-related 
response test. During the event-related response test, participants were asked to click a mouse 
when they heard a rare high-pitch tone within a series of low-pitch tones. The WAVi MedicalTM 
system assessed participants’ neurocognitive activity during the auditory evoked potential testing 
and reported quantitative metrics of cognitive performance operationalized as time (in 
milliseconds) and voltage (in microvolts).  
MoCA assessments were conducted and interpreted by trained research team members. 
One of the Perioperative Brian Health study’s (i.e., the data source for this study) investigators 
was MoCA-certified to administer and score MoCA assessments. This investigator trained 
research assistants to administer the MoCA v8.1 assessment based on Nasreddine’s (2017) 
MoCA v8.1 instructions for administering and scoring the MoCA. Research assistants 
successfully completed proctored simulated MoCA assessments on one another and at least two 
proctored clinical MoCA administrations prior to independently administering the MoCA 
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assessment to study participants. Nasreddine’s (2017) MoCA v8.1 standardized MoCA 
administration script was used for all MoCA assessments. The MoCA certified investigator 
scored all assessments. 
Following surgery and anesthesia, participants underwent postoperative neurocognitive 
assessments using the WAViMedTM system, Mini-Cog©, and CAM. All assessments were 
conducted and interpreted by trained research assistants. The CAM Short Form was used by all 
evaluators. The Mini-Cog©, along with the WAVi P300 Assessment, was used as a standardized 
interview upon which to conduct the CAM evaluation as recommended by Inouye (2003). 
Appendix B presents the Mini-Cog© assessment. Appendix C presents the CAM Short Form. 
Appendix D presents the WAViMedTM system’s patent.  
Target & Accessible Populations  
 The target population for this study was surgical patients over the age of 60 years 
presenting for elective, non-cardiac surgery and anesthesia. The accessible population was a 
convenience sample of surgical patients over the age of 60 years presenting to the VCU/VCUHS 
PACE clinic for preoperative evaluation and subsequently for surgery and anesthesia who 
underwent perioperative neurocognitive assessment while enrolled in the study “Perioperative 
Brain Health” – IRB HM20019839. VCU/VCUHS is a Level I trauma and regional referral 
center located in Richmond, Virginia that performs over 24,000 surgeries annually.  
VCU is an urban public research university ranked among the top 100 research 
universities by the National Science Foundation and received over 335 million dollars in 
research funding in 2020 (Annual Report, 2020). This setting increased the likelihood that data 
source study’s findings would be generalizable to a wide variety of surgical procedures and 
across a large spectrum of patient conditions and comorbidities. Richmond, Virginia’s 
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population by race is: 48% Black or African American, 40% White or Caucasian, 6% Hispanic 
or Latino, 4% 2 or more races, 2% Asian, and <1% other (U.S. Census Bureau, 2019). The U.S. 
population is 60% White or Caucasian, 18% Hispanic or Latino, 13% Black or African 
American, 6% Asian, 2% having a combined two or more races, and <1% other (U.S. Census 
Bureau, 2019). Therefore, generalizability of the study results to some ethnic groups (e.g. 
Hispanic or Latino) in other regions of the United States may be limited by the research setting. 
Sampling Strategy 
 For secondary data analysis, the sampling strategy is the method by which study 
participants are identified from the sampling frame (i.e., the available database) (Hulley et al., 
2013). For this study, the VCU/VCUHS REDCap® database: “Perioperative Brian Health” – PID 
22988 was the sampling frame. Available participants in this database underwent a variety of 
elective non-cardiac surgeries (e.g., orthopedic, urologic, oncologic, and general) and anesthesia 
at VCU/VCHU between November 2020 and April 2021 and participated in the study 
“Perioperative Brain Health” – IRB HM20019839. The number of participants in the sample was 
limited by the number of participants with complete data records that met this study’s eligibility 
criteria. Adequate data to meet study aims was expected as this study was not aimed at testing 
efficacy and similar EEG-based delirium studies analyzed data sets of between 12 and 23 
participants. (e.g., Evans et al., 2017; Mulkey et al., 2019; Vacas et al., 2016).  
The “Perioperative Brain Health” – IRB HM20019839 study employed a convenience 
sampling strategy. All initial screening, consent, and evaluation procedures took place in the 
VCU Health PACE clinic immediately after the potential study participant completed their 
scheduled preoperative anesthetic evaluation appointment. With the approval and collaboration 
of the Anesthesiologist Director of PACE, the investigators reviewed the PACE clinic schedule 
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each day to identify potential study participants scheduled for their preoperative anesthesia 
assessment in the PACE clinic the following day. Immediately following the patient's PACE 
clinic visit, PACE clinic staff asked each potential study participant if they would like to speak 
with a member of the “Perioperative Brain Health” study team about participating in an 
observational research study. Potential study participants were informed about the study by 
members of the research team and asked if they would like to participate. If yes, informed 
consent was obtained, and initial observations were completed in a PACE clinic exam room.  
Eligibility Criteria 
Two eligibility criteria were used when identifying study participants from the 
VCU/VCUHS REDCap® database: “Perioperative Brian Health” – PID 22988 sampling frame. 
Eligibility criteria and their rationale for both this study and the data source study are listed in 
Table eight.  
Table 8 
Eligibility Criteria and Rationale 
Current proposed study 
 Criteria Rationale 
Inclusion Sufficient data record to 
meet the aims of this 
study.  
A subset of participants in the study data base 
did not have adequately complete data records 
for analysis due to a combination of factors 
including patient safety, patient satisfaction, 
and COVID-19 related assessment limitations.  
Exclusion EEG artifact that 
precludes high quality 
assessment data (i.e., less 
than 30/40 artifact free 
P300 waveforms) 
Excessive EEG artifact may render erroneous 
P300 data. Therefore, records were excluded if 
less than 30/40 artifact free P300 waveforms 
were successfully captured during the four-
minute oddball paradigm assessment.   
Data Source 
Inclusion  Scheduled for an on-site 
preoperative anesthesia 
evaluation at the VCU 
Preoperative Assessment 
Communication and  
1) Brain function assessments were performed 
in the PACE clinic rather than the preoperative 
holding area so as to not delay the operating 




Table 8 Continued  
 
Inclusion  Education (PACE) clinic 
prior to surgery 
2) WAVi EEG Brain scans require an in-person 
assessment and cannot be performed remotely. 
 
Greater than 60 years of 
age 
 
1) The risk of an adult patient experiencing 
postoperative delirium (POD) increases with 
age 
2) The highest risk age group for POD is 
greater than 60 years of age. 
Anticipated to be under 
general anesthesia for 
greater than 1 hour  
Duration of anesthesia is associated with an 
increased risk of POD. 
 
Scheduled for surgery 
below the neck 
Per the WAVi Instruction Manual (Version 
0.9.8.17) "Do not use the WAVi headset on or 
near skin that is bruised or weakened due to 
either injury or the medical condition of the 
patient." 
Exclusion  Participants with 
documented baseline 
cognitive impairments 
that exclude them from 
providing informed 
consent 
Informed consent was required for this study 
and participants who are unable to provide 
informed consent due to a severe baseline 
cognitive impairment would not be able to 
perform the planned cognitive screening 
assessments. 
Self-reported inability to 
hear stimulus tone  
 
The WAVi auditory P300 tests assess the speed 
and power with which a patient's brain 
differentiates between a high pitched auditory 
tone and a low pitched auditory tone. Patients 
who were unable to hear these tones were not 
able to participate in the WAVi auditory P300 
brain assessments. 
Positive COVID-19 test 
result within the previous 
14 days documented in 
the patient’s health record 
 
To mitigate the risk of transmitting COVID-19 
from one participant to another, participants 
with a documented positive COVID-19 test 
result in their health record within the previous 
14 days were not eligible to participate. 
 
Power Analysis 
Power analysis enables a priori determination of sample size which enhances statistical 
conclusion validity and reduces the risk of a Type II error (Polit & Beck, 2017). A priori power 
analysis was performed using the Daniel Soper Statistical Power Calculator version 4.0 (Soper, 
2021). An effect size of 0.5 was anticipated given the frequency of POD noted in the literature 
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(American Geriatrics Society, 2015; American Society of Anesthesiologists, 2019). For the first 
study aim, a sample of 15 participants was analyzed. With two predictor variables, each 
considered independently as they measure two separate constructs of neurocognition, an 
anticipated effect size of 0.5, and α of 0.05, the a priori power of this analysis was calculated to 
be 0.94.  
For the second study aim, a sample of 10 participants was analyzed in this study. A doubly 
multivariate design using a repeated-measures multivariate analysis of variance (MANOVA) 
would be the ideal analysis for this aim. However, a priori power analysis indicated that results 
were likely to be substantially underpowered. With three predictors (i.e., the DV, the two groups, 
and the pre- to postoperative repeated analysis), an anticipated r2 = 0.5, α = 0.05, and n = 10, 
power would only be 0.46.  
The next best analysis for aim two would be a one-way MANOVA with pre- and 
postoperative scores transformed into a single difference score. However, with two predictors 
(i.e., the DV, and the two groups), an anticipated r2 = 0.5, α = 0.05, and n = 10, power would 
only improve to 0.61. A power of greater than 0.8 is desired to support statistical conclusion 
validity (Tabachnick and Fidell, 2013). For this reason, a pair of one-way ANOVA analyses 
were planned and conducted for the second study aim. With one response variable, an effect size 
of 0.5, and α of 0.05, the a priori power of this analysis was calculated to be 0.8.  
Data Management 
 Electronic study data was stored on a secure password protected university issued laptop 
and backed up on a secure password protected university-based cloud storage server. REDCap® 
was used to manage all data for this study. Hard copies of data generated during this study were 
securely stored in a locked file cabinet and only made accessible to research staff as needed. 
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REDCap® is a cloud-based research software platform designed for rapid data collection and 
secure data storage (Harris et al., 2009). REDCap® was specifically designed to provide 
researchers with an easy-to-use, customizable secure location for the collection, storage and 
dissemination of clinical data (Harris et al., 2009). All participants’ protected health information 
remained confidential. In addition to the study measures (i.e., WAVi MedicalTM P300 and 
MoCA), the following demographic data were collected and recorded for each participant: 
American Society of Anesthesiology Classification Score, age, sex, ethnicity, surgical procedure, 
length of surgery, primary anesthetic, and the administration of adjunct the potentially 
neuroprotective multimodal anesthetic agents under investigation (i.e., magnesium, lidocaine, 
and ketamine). Study data were only made available to members of the research team and VCU’s 
institutional review board (IRB) upon request. Data that could potentially identify individual 
participants (e.g., name, birthdate, date of surgery, etc.) will not be published. REDCap®’s 
embedded statistical software was used to perform descriptive statistics of the data set. Study 
data was exported from REDCap® into the IBM® Statistical Package for the Social Sciences 
(SPSS) version 26.0 to perform multivariate statistical analyses.  
Variables & Measures 
The predictor variables for the first study aim were auditory P300 amplitude and auditory 
P300 latency. The measurement for P300 amplitude was microvolts. The measurement for P300 
latency was milliseconds. Measurement data for the aforementioned variables were continuous, 
ratio level data. Continuous variables may take on any value of a given scale (Tabachnick & 
Fidell, 2013). The precision of measurement for continuous variables is limited by the 
measurement instrument as opposed to a scale itself (Tabachnick & Fidell, 2013). Ratio level 
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data is interval data (i.e., each value increment on the measurement scale is equally divided) that 
has a natural zero starting point (Tabachnick & Fidell, 2013).  
The criterion variable for the first study aim was participants’ preoperative MoCA score. 
MoCA is scored on a scale of 0-30 points with a score of 30 representing a correct answer on 
each assessment item. The measurement for MoCA score is a whole integer between zero and 
30. Data for this variable was continuous, ratio level data. 
The dependent variables for the second study aim were participants’ pre- to postoperative 
P300 amplitude and P300 latency change scores. The measurement for P300 amplitude was 
microvolts. The measurement for P300 latency was milliseconds. The independent variable for 
the second study aim was whether or not the participant received two or more potentially 
neuroprotective multimodal anesthetic adjunct medications (i.e., lidocaine, magnesium, and/or 
ketamine) intraoperatively. The measurement for this variable was YES or NO. Data for this 
variable was categorical. Table nine categorizes the study variables.  
Table 9 
Variables, Measurements, and Data Classification  
Study 
Aim 
Variable Dependent (DV) 
vs 
Independent (IV) 
Measurement Data Classification 
1 MoCA Score DV Whole Integer 
(0-30) 
Continuous, Ratio 
P300 Amplitude IV Microvolts Continuous, Ratio 
P300 Latency IV Milliseconds Continuous, Ratio 
2 P300 Amplitude 
Change Score 
DV Microvolts Continuous, Ratio 
P300 Latency 
Change Score 
DV Milliseconds Continuous, Ratio 
PNMMAAa IV YES / NO Categorical 




Protection of Human Participants  
 Data for this study was secondary data collected form the VCU/VCUHS REDCap® 
database: “Perioperative Brian Health” – PID 22988. All participant’s protected health 
information was kept confidential in accordance with the Health Insurance Portability and 
Accountability ACT (HIPAA) of 1996 throughout this study. No personal identifiable patient 
information was collected for this study. This study did not require informed consent as it 
represented no more than minimal risk to the study patient. All participants whose records were 
utilized for this study previously gave informed consent to participate in the study “Perioperative 
Brain Health” – IRB HM20019839. The signed IRB approved consent forms for the study 
“Perioperative Brain Health” – IRB HM20019839 stated “In the future, identifiers might be 
removed from the information you provide in this study, and after that removal, the information 
could be used for other research studies by this study team or another researcher without asking 
you for additional consent.”  
Data Cleaning 
 After data for this study was exported from REDCap®, variables were named and data 
was evaluated as described by Tabachnick and Fidell (2013) chapter four. First, accuracy of the 
recorded data was assessed. Next, the data set was evaluated for missing data and would have 
been reconciled by performing a value analysis to evaluate for magnitude and patterns of missing 
data. Not missing data was identified. Third, data fit was assessed for the assumptions of each 
multivariate statistical analysis. Fourth, data would have been transformed if necessary. No data 
required transformation. Finally, the data set was evaluated for outliers which would have been 





Descriptive statistics portray a study’s sample population and use this information to 
describe the reference population (Tabachnick and Fidell, 2013). This study generated 
descriptive statistics to depict the characteristics of a sample of older surgical patients presenting 
for surgery and anesthesia who participated in the study “Perioperative Brain Health” – IRB 
HM20019839 and met eligibility criteria for this study. The following descriptive statistics are 
reported in chapter five: 1) sample size, 2) age (range and mean), 3) sex (% female vs male), 4) 
ethnicity (% African American, Caucasian, Hispanic or Latino, 2 or more races, Asian, and 
other), 5) American Society of Anesthesiology Classification Score, 6) surgical procedure 
(nominal), 7) length of surgery (range and mean), 8) type of anesthetic (nominal), 9) duration of 
anesthetic, and 10) the administration of potentially neuroprotective multimodal anesthetic 
adjunct medications (categorical). 
Multivariate Statistics 
Regression was used in the evaluation of data for the first study aim to assess whether 
auditory P300 amplitude (in microvolts) or auditory P300 latency (in milliseconds) predicted 
participants’ MoCA scores. Regression was appropriate for this analysis as it aims to create a 
linear combination of independent variables that optimally predict a dependent variable and 
identify the relative contribution of each independent variable to the total variance explained by 
the model. Once collected, data were analyzed for the following eight assumptions prior to 
performing regression analysis (Laerd, 2021a):  
1. The dependent variable was interval or ratio level data 
2. There were two or more independent variables with continuous data 
3. Independence of observations was present 
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4. Normality was present 
5. There was a linear relationship between the two variables 
6. Homoscedasticity was present  
7. Multicollinearity was absent  
8. There were no significant outliers  
Assumptions one, two, and three were self-evident from the data set as displayed in tables nine 
and 10. Histograms were generated to assess normality. Scatterplots were generated to assess 
linearity, homoscedasticity, and outliers. A Pearson correlation matrix was generated to assess 
for multicollinearity. The results for assumption testing including histograms, scatterplots, and 
SPSS output are discussed and displayed in chapter five. Each variable was considered 
independently as they measure two separate constructs of neurocognition, namely cognitive 
resources (i.e., brain power) and cognitive efficiency (i.e., brain speed). 
The ideal statistical analysis for the second study aim would have been a doubly 
multivariate design using a repeated-measures multivariate analysis of variance (MANOVA). 
This approach would enable the evaluation of multiple non-commensurate dependent variables 
(e.g., P300 latency and P300 amplitude which are measured on different scales: microvolts and 
milliseconds respectively) that are repeatedly measured (e.g., pre- and postoperatively) 
(Tabachnick and Fidell, 2013). This design enables singly multivariate evaluation of the 
between-subjects effect (i.e., those who received potentially neuroprotective multimodal 
anesthetic adjunct medications versus those who did not) and doubly multivariate evaluation of 
the within-subjects effects (i.e., pre- versus postoperative values of the dependent variables). 
This analysis would test for parallelism, flatness, and levels (Tabachnick and Fidell, 2013). Of 
these three, parallelism testing would be of the highest utility for this study to evaluate for a 
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difference in neurocognitive metrics between participants who received potentially 
neuroprotective anesthetics adjuncts and participants who did not. The sample size required for 
this analysis is set by the between-subjects effect according to the conditions for MANOVA. 
With the current sample size available in the data source study (i.e., postoperative assessment 
n=10), results from this analysis were estimated to be substantially underpowered in the a priori 
power analysis. For example, with three predictors (i.e., the DV, the two groups, and the pre- to 
postoperative repeated analysis), an anticipated r2 = 0.5, α = 0.05, and n = 10, power would only 
be 0.46. To support statistical conclusion validity, a power of greater than 0.8 is desired 
(Tabachnick and Fidell, 2013). For this reason, a doubly multivariate design using a repeated-
measures MANOVA was not used for this study as this design uses one degree of freedom 
comparing pre- to postoperative scores and one degree of freedom for the two groups.  
 The second best statistical analysis for the second study aim would have been to conduct 
a one-way MANOVA by converting the pre- and postoperative scores into a single difference 
score. This would reduce the number of predictors by one and reduce the degrees of freedom 
used by one. However, with two predictors (i.e., the DV, and the two groups), an anticipated r2 = 
0.5, α = 0.05, and n = 10, power would only improve to 0.61. For this reason, a one-way 
MANOVA of difference scores was not used for this study. 
A pair of one-way ANOVA analyses were conducted for the second study aim to 
determine whether a difference exists in pre-and postoperative P300 amplitude (in microvolts) 
and P300 latency (in milliseconds) change scores between participants who received potentially 
neuroprotective multimodal anesthetic adjunct medications and those who did not. ANOVA is 
appropriate for this analysis because it aims to determine if a statistically significant difference 
exists between the means of two or more independent groups, minimizes the effect of the degrees 
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of freedom, and maximizes the power for a small sample (Tabachnick and Fidell, 2013). With 
one response variable, an effect size of 0.5, and α of 0.05, the a priori power of this analysis was 
calculated to be 0.8. After being collected, data was analyzed for the following six assumptions 
prior to performing an ANOVA (Laerd, 2021b):  
1. The dependent variable was interval or ratio level data 
2. The independent variable consisted of two or more independent, categorical groups 
3. There was independence of observations 
4. There were no significant outliers 
5. The dependent variables were approximately normally distributed for each category of 
the independent variable 
6. Homogeneity of variance was present  
Assumptions one, two, and three were self-evident from the data set as displayed in tables nine 
and 10. Histograms were generated to assess normality. Scatterplots were generated to assess 
linearity, homogeneity of variance, and outliers. Chapter five includes a discussion of the results 
of assumption testing and displays figures of the histograms, scatterplots, and SPSS output 
generated in this process.  
Assumptions & Limitations 
The principal assumption in this study is that the WAVi MedicalTM system provides valid 
and reliable assessment of P300 waveforms in response to an oddball paradigm as the device was 
not independently validated by the research team. This assumption is reasonable given: 1) 
previously reported utility of P300 evoked potentials as a neurocognitive assessment metric (Sur 
& Sinha, 2009; Parra et al., 2012; Yener, 2013, van Dinteren 2014; Grover et al., 2017; Clayton 
et al. 2020), 2) reported success using the WAVi MedicalTM system for conducting P300 evoked 
 
 90 
potential neurocognitive assessments in at least two recent publications (Grover et al., 2017; 
Clayton et al., 2020), and 3) similar ongoing neurocognition clinical studies are employing the 
WAVi MedicalTM system (National Institutes of Health, 2018; Clinicaltrials.gov, 2018). Mulkey 
et al. (2019) accepted comparable assumptions as the first investigators to evaluate the potential 
utility of the Ceribell device (Ceribell, Inc., 2018), an FDA-cleared limited lead EEG device, for 
delirium identification and assessment among ICU patients.  
One limitation of a retrospective secondary data study is that causality cannot be 
determined (Polit and Beck, 2017). As a proof-of-concept study, this study primarily sought to 
identify associations that may be useful in generating hypotheses to guide future research.  
Another potential limitation of a study that uses secondary data is that data could be inaccurate or 
incomplete (Hulley et al., 2013). Additionally, data may have been collected from an unideal 
population (e.g., unequal proportions of gender, age, or ethnicity) and important covariates may 
not have been identified and recorded (Hulley et al., 2013). A third potential limitation of this 
study is the relatively higher likelihood of a Type II error (i.e., failing to reject a false null 
hypothesis) given the relatively small postoperative assessment sample size available from the 
data source study. A more detailed discussion of limitations is presented in chapter six.  
Chapter Summary 
This study was important because the WAVi MedicalTM system may one day enable 
anesthesia providers to: 1) rapidly perform a valid and reliable neurocognitive assessment that is 
more detailed, sensitive, and specific than questionnaire-based neurocognitive screening tools, 2) 
predict POD risk and stratify patients into risk categories, 3) detect mild cognitive impairments 
currently missed by brief cognitive screening tools (e.g., Mini-Cog©), and 4) objectively track 
the progression of postoperative cognitive changes over time. Specifically, this study 
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investigated the potential clinical utility of P300 AEP (i.e., amplitude and latency) obtainable 
with a POC EEG brain health assessment device. This contribution was significant because, 
pending further investigation, a device capable of rapidly and reliably predicting, identifying, 
and tracking perioperative neurocognitive disorders may enhance anesthesia providers’ ability to 
develop and evaluate the effectiveness of perioperative brain health protection protocols and 
clinical pathways in an effort to reduce the incidence and severity of POD in older surgical 


























Chapter 5: Results 
Chapter Overview 
The purpose of this study was to explore baseline and postoperative neurocognitive 
characteristics that may help to establish novel predictive and trend metrics for perioperative 
neurocognitive assessment in older surgical patients. In this study, relationships between P300 
AEPs and MoCA scores were explored, and differences in pre- to postoperative P300 AEP 
change scores between participants who received two or more potentially neuroprotective 
multimodal anesthetic adjunct medications versus those who did not were evaluated. This study 
was important because neurobiomarkers obtainable with the POC EEG brain health assessment 
device, WAVi MedicalTM (Boulder, CO), might one day provide anesthesia providers with a 
more detailed perioperative assessment of a patient’s brain, the primary target of anesthesia, than 
is currently available with questionnaire-based assessment tools (e.g., MoCA, Mini-Cog©, and 
CAM). 
A non-experimental ex post facto secondary data analysis design was used to 
retrospectively: 1) compare participants’ baseline P300 AEPs to MoCA scores before surgery 
and anesthesia and 2) evaluate for group differences in pre- to postoperative P300 AEP change 
scores between participants who received two or more potentially neuroprotective multimodal 
anesthetic adjunct medications versus those who did not.  
Chapter five offers a succinct presentation of the study’s results. Results are presented in 
a narrative format supplemented with figures and tables. The chapter begins with a description of 
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the variables and data cleaning process and is followed by a summary of the statistical findings 
for each of the two study aims.  
Review of Data Acquisition 
Following IRB approval from VCU, data records meeting this study’s criteria were 
extracted from the VCU/VCUHS REDCap® database: “Perioperative Brian Health” – PID 
22988. As previously mentioned, data in this database was collected using a longitudinal, 
repeated measures design to conduct a prospective observational trial with a set of pretests and 
multi-observation post-tests. At the time of data extraction for the current study, the database 
contained 20 participant records. After the evaluation of each record for sufficient data to meet 
this study’s inclusion and exclusion criteria, the final sample size was n = 15 for the first study 
aim and n = 10 for the second study aim. Figure 23 illustrates the study’s exclusion criteria for 
both study aims.  
Figure 23  




Data Preparation and Cleaning 
 Data was inspected for accuracy and missing values. No missing values were identified. 
Data was coded using SPSS and assigned as either scale (i.e., continuous) or nominal (i.e., 
categorical) in SPSS for the purpose of analysis. Table 10 lists the study variables and their 
respective coding.  
Table 10 
Study Variables and Coding 
Variable Coding Category 
Age Age in years Scale / Continuous 
Sex 1 = “Male” 
2 = “Female” 
Nominal / Categorical 
Ethnicity 1 = “African American” 
2 = “Caucasian”  
3 = “Hispanic or Latino”a 
4 = “Asian”a 
5 = “2 or more races”a 
6 = “Self-identify”a 
Nominal / Categorical 
ASA Score 1 = “ASA I - A normal healthy patient” 
2 = “ASA II - A patient with mild 
systemic disease” 
3 = “ASA III - A patient with severe 
systemic disease” 
4 = “ASA IV - A patient with severe 
systemic disease that is a constant threat 
to life” 
5 = “ASA V - A moribund patient who 
is not expected to survive without the 
operation”a 
6 = “ASA VI - A declared brain-dead 
patient whose organs are being removed 
for donor purposes”a 
Nominal / Categorical 
MoCA Score Score 0-30 Scale / Continuous  
P300 
Amplitude 
Amplitude in microvolts Scale / Continuous 
P300 Latency Latency in milliseconds Scale / Continuous 
Primary 
Anesthetic 
1 = “Sevoflurane” 
2 = “Isoflurane”a 
3 = “Desflurane”a 
Nominal / Categorical 
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Table 10 Continued  
Primary 
Anesthetic 
4 = “Propofol” 
5 = “Other”a 
Nominal / Categorical 
Length of 
Anesthesia 
Time in minutes Scale / Continuous 
Surgical 
Procedure 
0 = “Spine” 
1 = “Shoulder Arthroplasty” 
2 = “Major Invasive Urology” 
3 = “Laparoscopic Intraabdominal” 
Nominal / Categorical 
Length of 
Surgery 
Time in minutes Scale / Continuous 
PNMMA 
Received (≥2) 
0 = “No” 
1 = “Yes” 




Pre- to postoperative amplitude change 
in microvolts  




Pre- to postoperative latency change in 
milliseconds 
Scale / Continuous 
a No study participants were in this category   
Descriptive Statistical Analysis 
Descriptive analysis was completed using REDCap®’s imbedded statistical software. The 
following descriptive statistics are presented in a narrative format supplemented with figures and 
tables: 1) sample size, 2) age (range and mean), 3) sex (% female vs male), 4) ethnicity (% 
African American and Caucasian), 5) American Society of Anesthesiology Classification Score, 
6) surgical procedure (nominal), 7) length of surgery (range and mean), 8) type of anesthetic 
(nominal), 9) duration of anesthetic, and 10) the administration of PNMMA agents (categorical). 
For the first study aim, evaluate the ability of participants’ preoperative baseline P300 
latency and P300 amplitude to predict participants’ cognitive function, the final sample size was 
15. Participants’ age ranged from 61-82. The mean age was 72. Four participants identified as 
female (27%), and 11 participants identified as male (73%). Four participants identified as 
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African American (27%), and 11 participants identified as Caucasian (73%). Table 11 
summarizes the descriptive statistics for the study aim one.  
Table 11 
Descriptive Statistics – Aim 1 
Variable Continuous: Mean (Min, 
Max) 
Categorical: n (%) 
Sample Size n = 15 






















For study aim two, evaluate for group differences in pre- to postoperative P300 AEP 
change scores between participants who received two or more potentially neuroprotective 
multimodal anesthetic adjunct medications versus those who did not, the final sample size was 
10. The sample size of group one (i.e., participants who did receive two or more PNMMA 
medications) was six. Group one participants’ age ranged from 66-79. The mean age was 73.2. 
Three participants identified as female (50%), and three participants identified as male (50%). 
Two participants identified as African American (33%), and four participants identified as 
Caucasian (67%). Two participants’ (33%) ASA was II, three participants’ (50%) ASA was III, 
and one participant’s (17%) ASA was IV. All participants in group one received a sevoflurane-
based anesthetic. Group one’s duration of anesthesia ranged from 200-495 minutes. The mean 
duration of anesthesia for group one was 299 minutes. Two participants (33%) underwent 
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laparoscopic intra-abdominal surgery. Three participants (50%) underwent major invasive 
urologic surgery. One participant (17%) underwent shoulder arthroplasty. Group one 
participants’ length of surgery ranged from 150-428 minutes. The mean duration of surgery for 
group one was 253 minutes.  
The sample size of group two (i.e., participants who did not receive two or more 
PNMMA medications) was four. Group two participants’ age ranged from 72-82. The mean age 
was 76.5. One participant identified as female (25%), and three participants identified as male 
(75%). All four participants identified as Caucasian (100%). One participant’s (25%) ASA was 
II and three participants’ (75%) ASA was III. One participant (25%) in group two received a 
propofol-based anesthetic, and three participants (75%) in group two received a sevoflurane-
based anesthetic. Group two’s duration of anesthesia ranged from 97-293 minutes. The mean 
duration of anesthesia for group two was 218 minutes. Two participants (50%) underwent major 
orthopedic spine surgery. Two participants (50%) underwent shoulder arthroplasty. Group two 
participants’ length of surgery ranged from 69-214 minutes. The mean duration of surgery for 
group two was 167 minutes. Table 12 summarizes the descriptive statistics for the second study 
aim. 
As previously noted, the target population for this study was surgical patients over the 
age of 60 years presenting for elective, non-cardiac surgery and anesthesia. The accessible 
population was a convenience sample of surgical patients over the age of 60 years presenting to 
the VCU/VCUHS PACE clinic for preoperative evaluation and subsequently for surgery and 
anesthesia who underwent perioperative neurocognitive assessment while enrolled in the study 
“Perioperative Brain Health” – IRB HM20019839. This setting increased the likelihood that 




Descriptive Statistics – Aim 2 
Variable Group 1 
 
PNMMA – Yes 
 
Continuous: Mean (Min, Max) 
Categorical: n (%) 
Group 2 
 
PNMMA – No 
 
Continuous: Mean (Min, Max) 
Categorical: n (%) 
Sample Size  n = 6 n= 4 







































3 (75)  
Length of Anesthesia 
(Minutes) 
 
299 (200, 495)  
 




Major Invasive Urology 
Spine 











Length of Surgery 
(Minutes) 
 
253 (159, 428) 
 
167 (69, 214) 
 
spectrum of patient conditions and comorbidities. Given the sample size for this study, a true 
representation of the diversity of the general population of older surgical patients is not 
realistically feasible. However, the sample population is reasonably diverse including 




Assumption Testing  
 Prior to performing multivariate statistical analysis, each variable was evaluated for the 
following assumptions:  
Regression: 
1. The dependent variable was interval or ratio level data 
2. There were two or more independent variables with continuous data 
3. Independence of observations was present 
4. Normality was present 
5. There was a linear relationship between the two variables 
6. Homoscedasticity was present  
7. Multicollinearity was absent  
8. There were no significant outliers  
Assumptions one, two, and three are self-evident from the data set as previously displayed in 
tables nine and ten. Histograms were generated to assess for normality (i.e., a normal distribution 
of the variables in a data set), skewness (i.e., symmetry of a data set’s distribution), and kurtosis 
(i.e., peakedness of a data set’s distribution) (Tabachnick and Fidell, 2013).  
Skewness and kurtosis can be assessed both graphically (e.g., histogram with a curve 
overlay) and statistically. A graphed data set that is positively skewed has an increased number 
of data points on the left side of the histogram and a long right-sided tail on the curve overlay. A 
graphed data set that is negatively skewed has an increased number of data points on the right 
side of the histogram and a long left-sided tail on the curve overlay. Positive kurtosis refers to a 
tall, peaked distribution with short, thick tails on a histogram relative to a normal distribution, 
and negative kurtosis refers to a flattened distribution (Tabachnick and Fidell, 2013). Skewness 
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and kurtosis statistics can be converted to z-scores by dividing the statistic by its standard error 
with the acceptable range being a z-score of negative three to positive three (Tabachnick and 
Fidell, 2013). 
Scatterplots were generated to assess for linearity (i.e., a straight-line forming association 
between two variables), homoscedasticity (i.e., one variable’s variance is identical across all 
values for another variable), and outliers (i.e., data points that significantly differ from the 
majority of other data points within a data set) (Tabachnick and Fidell, 2013). A Pearson 
correlation matrix of the independent variables was created to assess for multicollinearity (i.e., 
correlated independent variables) (Tabachnick and Fidell, 2013). A Pearson correlation of less 
than 0.8 is indicative of an acceptable absence of multicollinearity among variables (Tabachnick 
and Fidell, 2013).  
For aim one, the DV was MoCA score and the IVs were P300 amplitude and latency. The 
distribution of the DV (i.e., MoCA Score) exhibited a negative skewness (i.e., skewed left) of -
1.31 (standard error 0.58) and positive kurtosis of 1.05 (standard error 1.12). The distribution of 
the IV amplitude exhibited a slight positive skewness (i.e. skewed right) of 0.55 (standard error 
0.58) and slight positive kurtosis of 0.32 (standard error 1.12). The distribution of the IV latency 
exhibited a slight positive skewness (i.e., skewed right) of 0.15 (standard error 0.58) and slight 
positive kurtosis of 0.36 (standard error 1.12). Figures 24, 25, and 26 display the histograms with 
a curve overlay generated in SPSS for aim one. Figure 27 displays the results of statistical 
analysis for skewness and kurtosis of the aim one variables. 
The MoCA-amplitude scatterplot exhibited a weak negative relationship. Homogeneity of 
variance was present and appeared relatively consistent, and no extreme outliers were noted. 




Histogram of the Distribution of the Aim One DV, MoCA Score 
 
weak positive relationship. Homogeneity of variance was present and appeared relatively 
consistent on the MoCA-latency scatterplot. No extreme outliers were noted. 
Figure 25 





Histogram of the Distribution of the Aim One IV, Latency 
 
Figure 27 
SPSS Output: Skewness and Kurtosis of the Aim One Variables 
 
Figure 29 displays the MoCA-latency scatterplot. A Pearson correlation matrix was 
generated to assess for multicollinearity between the two independent variables (i.e., amplitude 
and latency). The Pearson correlation was calculated to be r = -0.111, n = 15, and the 
relationship was not significant p = 0.695. Multicollinearity was not present. Figure 30 displays 




Scatterplot of the Distribution of the Aim One IV, Amplitude and DV, MoCA Score 
 
Figure 29 







SPSS Output: Collinearity Statistics of the Aim One Variables 
 
ANOVA: 
1. The dependent variable was interval or ratio level data 
2. The independent variable consisted of two or more independent, categorical groups 
3. There was independence of observations 
4. There were no significant outliers 
5. The dependent variables were approximately normally distributed for each category of 
the independent variable 
6. Homogeneity of variance was present  
Assumptions one, two, and three for aim two were also self-evident from the data set previously 
displayed in tables nine and 10. Histograms were generated to assess for normality (i.e., a normal 
distribution of the variables in a data set), skewness (i.e., symmetry of a data set’s distribution), 
and kurtosis (i.e., peakedness of a data set’s distribution) (Tabachnick and Fidell, 2013).  
As previously noted for aim one, skewness and kurtosis may be assessed graphically 
(e.g., histogram with a curve overlay), statistically, or by a combination of the two. A positively 
skewed data set presents as an increased number of data points on the left side of the histogram 
and a long right-sided tail on the curve overlay. A negatively skewed data set presents as an 
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increased number of data points on the right side of the histogram and a long left-sided tail on the 
curve overlay. Positive kurtosis presents as a tall, peaked distribution with short, thick tails on a 
histogram, whereas negative kurtosis presents as a flattened curve relative to a normal 
distribution (Tabachnick and Fidell, 2013). The calculated statistics for skewness and kurtosis 
can be converted to z-scores be dividing the statistic by its standard error. The generally 
acceptable range for these values is a z-score between negative and positive three (Tabachnick 
and Fidell, 2013). 
Scatterplots were generated to assess for linearity (i.e., a straight-line forming association 
between two variables), homoscedasticity (i.e., one variable’s variance is identical across all 
values for another variable), and outliers (i.e., data points that significantly differ from the 
majority of other data points within a data set) (Tabachnick and Fidell, 2013). For aim two, the 
DVs were P300 amplitude and latency change scores and the IV was whether or not (i.e., Yes / 
No) participants received two or more PNMMA adjunct medications. 
The distribution of the DV P300 amplitude change score exhibited a slight positive 
skewness (i.e., skewed right) of 0.15 (standard error 0.69) and negative kurtosis of -2.189 
(standard error 1.33). The distribution of the DV P300 latency change score exhibited a slight 
positive skewness (i.e., skewed right) of 0.05 (standard error 0.69) and slight negative kurtosis of 
-0.55 (standard error 1.33). The distribution of the IV PNMMA (Yes / No) exhibited a slight 
negative skewness (i.e. skewed left) of -0.48 (standard error  0.69) and negative kurtosis of -2.28 
(standard error 1.34). Figures 31, 32, and 33 display the histograms with a normal curve overlay 
generated for aim two. Figure 34 displays the results of statistical analysis for skewness and 





Histogram of the Distribution of the Aim Two DV, Amplitude Change Score 
  
Figure 32 





Histogram of the Distribution of the Aim Two IV, PNMMA (Yes / No) 
 
Figure 34 
SPSS Output: Skewness and Kurtosis of the Aim Two Variables 
 
The PNMMA-amplitude boxplot displayed in Figure 35 exhibited a positive association 
between receiving PNMMA (Yes / No) and amplitude change scores. The PNMMA-latency 





Boxplot of the Aim Two DV, Amplitude Change Score and IV, PNMMA (Yes / No)  
 
Figure 36 
Boxplot of the Aim Two DV, Latency Change Score and IV, PNMMA (Yes / No)  
 
(Yes / No) and latency change scores. Homogeneity of variance was present and appeared 




The first study aim was to evaluate the ability of participants’ preoperative baseline P300 
latency (i.e., brain speed) and P300 amplitude (i.e., brain power) to predict participants’ 
cognitive function. This study used regression to understand whether auditory P300 amplitude 
(in microvolts) and auditory P300 latency (in milliseconds) predict cognitive function among 
older surgical patients as assessed by MoCA. Each variable was considered independently as 
they measure two separate constructs of neurocognition, namely cognitive resources (i.e., brain 
power) and cognitive efficiency (i.e., brain speed).  
Hypothesis one (H1) assessed for a relationship between participants P300 amplitude and 
MoCA scores. 
Hypothesis #1: Lower P300 amplitude will be predictive of lower MoCA scores.  
H1 was tested using linear regression. A simple linear regression was calculated to predict 
participants’ MoCA scores based on their P300 amplitude. The regression equation was not 
significant (F(1,13) = 0.021, p > 0.05) with an r2 of 0.002. In this sample, P300 amplitude was 
not a significant predictor of MoCA score. Figures 37 and 38 show the model summary and 
coefficients for the analysis of H1 respectively.  
Figure 37 





SPSS Output: Coefficients for Analysis of H1 
 
Hypothesis two (H2) assessed for a relationship between participants P300 latency and 
MoCA scores. 
Hypothesis #2: Increased P300 latency will be predictive of lower MoCA scores.  
H2 was tested using linear regression. A simple linear regression was calculated to predict 
participants’ MoCA scores based on their P300 latency. The regression equation was not 
significant (F(1,13) = 0.052, p > 0.05) with an r2 of 0.004. In this sample, P300 latency was not a 
significant predictor of MoCA score. Figures 39 and 40 show the model summary and 
coefficients for the analysis of H2 respectively.  
Figure 39 








SPSS Output: Coefficients for Analysis of H2 
 
The second study aim was to evaluate for group differences in pre- to postoperative P300 
AEP change scores (i.e., amplitude (in microvolts) and latency (in milliseconds)) between 
participants who received two or more PNMMA medications (i.e., magnesium, lidocaine, and/or 
ketamine) versus those who did not.  
Hypothesis three (H3) assessed for a difference in P300 amplitude between participants 
who received two or more PNMMA medications versus those who did not. 
Hypothesis #3: Participants who received two or more potentially neuroprotective 
multimodal anesthetic agents will demonstrate a larger positive change in their P300 
amplitude, measured as a pre- to postoperative change score in microvolts. 
A one-way ANOVA was computed to determine if participants who received two or more 
PNMMA agents demonstrated a larger positive change in their P300 amplitude than participants 
who did not receive these medications intraoperatively.  
As seen in Figure 41, participants who did not receive two or more PNMMA medications 
had a mean reduction in their P300 amplitude (-3.5). However, participants who did receive two 
or more PNMMA medications had a mean increase in their P300 amplitude (4.3). These findings 






SPSS Output: Descriptives for Analysis of H3 
 
As seen in Figure 42, in this sample, a significant difference was identified between the two 
groups (F(1,8) = 12.093, p < 0.05).  
Figure 42 
SPSS Output: ANOVA for Analysis of H3 
 
Post hoc analysis revealed that participants who received two or more PNMMA medications 
demonstrated a larger positive postoperative change in their P300 amplitude (M = 4.33, sd = 
4.29, 95% CI = [-0.17, 8.83]) than participants who did not (M = -3.45, sd = 1.19, 95% CI = [-
5.34, -1.56]). 
Hypothesis four (H4) assessed for a difference in P300 latency between participants who 
received two or more PNMMA medications versus those who did not. 
Hypothesis #4: Participants who received two or more potentially neuroprotective 
multimodal anesthetic agents will demonstrate a smaller degree of prolongation in their 
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P300 latency relative to their baseline, measured as a pre- to postoperative change score 
in milliseconds.  
A one-way ANOVA was computed to determine if participants who received two or more 
PNMMA agents demonstrated a smaller degree of prolongation in their P300 latency than 
participants who did not receive these medications intraoperatively. No significant difference 
was identified (F(1, 8) = 0.245, p > 0.05). Participants’ P300 latency change scores did not differ 
significantly between the two groups. Participants who received two or more PNMMA agents 
had a mean change score of 14.76 milliseconds (sd = 76.01, 95% CI = [-65.10, 94.43]). 
Participants who did not receive two or more PNMMA agents had a mean change score of -9 
milliseconds (sd = 70.53, 95% CI = [-121.23, 103.23]). Figures 43 and 44 show the descriptives 
and ANOVA for the analysis of H4.  
Figure 43 
SPSS Output: Descriptives for Analysis of H4 
 
Post Hoc Power Analysis 
Post hoc power analysis was performed using the Daniel Soper Statistical Power Calculator 
version 4.0 (Soper, 2021). In the post hoc power analysis, the power of the first study aim was 
calculated to be very low at 0.05 for each predictor (n = 15, 2 predictors (considered 
independently as they measure two separate constructs of neurocognition) calculated effect size 
of 0.002 (amplitude) and 0.004 (latency), and α of 0.05). This result was lower than anticipated 
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based on the a priori power analysis and indicates a 5% chance of detecting an effect if one 
exists and a 95% chance of a Type II error, a false acceptance of the null hypothesis.  
Figure 44 
SPSS Output: ANOVA for Analysis of H4 
 
For second study aim, hypothesis three, the post hoc power was calculated to be acceptable at 
0.94 (n = 10, 1 response, calculated effect size of 0.6, and α of 0.05). This result was slightly 
higher than anticipated based on the a priori power analysis and indicates an 94% chance of 
detecting an effect if one exists and a 16% chance of a Type II error, false acceptance of the null 
hypothesis. For second study aim, hypothesis four, the post hoc power was calculated to be very 
low at 0.08 (n = 10, 1 response, calculated effect size of 0.03, and α of 0.05). This result was 
lower than anticipated based on the a priori power analysis and indicates an 8% chance of 
detecting an effect if one exists and a 92% chance of a Type II error, false acceptance of the null 
hypothesis. 
Chapter Summary 
Chapter five presented the results of this study’s statistical analyses to evaluate the ability 
of participants’ preoperative baseline P300 latency and amplitude to predict participants’ MoCA 
scores and assess for group differences in pre- to postoperative P300 AEP change scores between 
participants who received two or more PNMMA medications versus those who did not. Linear 
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regression was used to analyze the relationship between participants’ preoperative baseline P300 
latency and amplitude and MoCA scores. No significant relationship was identified between 
either P300 latency or amplitude and MoCA scores. ANOVA was used to evaluate for 
differences in pre- to postoperative P300 AEP change scores between participants who received 
two or more PNMMA medications and those who did not. A statistically significant 
postoperative positive change in P300 amplitude was identified in participants who received two 
or more PNMMA medications (e.g., lidocaine, ketamine, magnesium) versus those who did not. 
No significant postoperative change in P300 latency was identified in participants who received 
two or more PNMMA medications (e.g., lidocaine, ketamine, magnesium) versus those who did 
not. Chapter six discusses potential clinical implications of these findings, study limitations, and 






















Chapter 6: Conclusions and Recommendations 
Chapter Overview 
 Chapter six presents a study summary and the important conclusions drawn from the data 
presented in chapter five. The potential clinical implications for anesthesia practice are 
discussed. The chapter concludes with recommendations for future research. 
The Problem 
The perioperative brain health of older surgical patients is a public health and research 
priority (American Society of Anesthesiologists, 2019). POD is a risk factor for long-term 
neurocognitive decline, and the rate of decline is associated with POD severity (Vasunilashorn et 
al., 2018). Baseline cognitive function is a strong, independent predictor for POD (Culley et al., 
2017). The International Perioperative Neurotoxicity Working Group recommends preoperative 
baseline neurocognitive assessment for older surgical patients (Berger, et al., 2018). Cognitive 
screening tools trialed in anesthesia are not routinely incorporated into clinical practice related to 
validity, reliability, or practicality considerations (Berger, et al., 2018). The ideal perioperative 
neurocognitive assessment would be rapid, easily-administrable, valid, reliable, automatically 
scored, void of language, cultural, and education bias and cost-efficient (Axley & Schenning, 
2015). No such assessment has been identified to date.  
Anesthesia providers routinely assess multiple organ systems (e.g., cardiovascular—
auscultation of heart sounds, METs; respiratory—auscultation of lung sounds; laboratory 
values—hemoglobin/hematocrit, glucose, electrolytes, hepatic enzymes). However, the brain, 
anesthesia’s primary target, is rarely assessed beyond orientation to person, place, time and task.  
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Crosby et al. (2011) lamented this problem: 
…that we currently make no effort to identify [older patients with a vulnerable brain 
state] preoperatively is an embarrassing state of affairs considering that… perioperative 
cognitive morbidity in the elderly is so common and costly (p. 1267).  
One major barrier to rigorous and routine perioperative neurocognitive evaluation is that no 
easily-administrable, rapid, reliable, highly sensitive and specific assessment of an individual’s 
cognitive resources and efficiency is currently available.  
A POC EEG device capable of rapidly performing easily-administrable, reliable, 
sensitive, and specific neurocognitive assessments at the bedside might enable anesthesia 
providers to better assess baseline neurocognitive function in older surgical patients prior to 
surgery and anesthesia. Objective assessments derived from a POC EEG-based neurocognitive 
assessment device may detect neurocognitive baseline changes as well as postoperative changes 
(e.g., mild or even subsyndromal cognitive impairments) that are currently missed in a subset of 
patients by clinically utilized cognitive assessment tools (e.g., A&O x4). 
Study Purpose, Research Questions, and Hypotheses  
As a proof-of-concept study, this research primarily sought to explore associations and 
generate hypotheses to guide future research. Specifically, the purpose of the study was to 
explore potential neurobiomarkers derived from EEG-based P300 auditory evoked potentials 
(AEPs) that may serve as both predictive and trend metrics of perioperative neurocognitive 
function in older surgical patients. Such neurobiomarkers might facilitate a more rigorous 
perioperative assessment of a patient’s brain state than do questionnaire-based assessment tools 
(e.g., What is your name?, Where are you right now?, What is today’s date?, Do you know why 
you are here?). In this study, relationships between P300 AEPs and MoCA scores were explored 
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and differences in pre- to postoperative P300 AEP change scores between participants who 
received two or more PNMMA adjunct medications versus those who did not were evaluated. 
Pending further investigation, EEG-based neurobiomarkers may assist the development of 
perioperative brain health protection protocols that reduce the incidence and/or severity of 
perioperative neurocognitive disorders in older surgical patients. 
Review of Theory  
Donabedian’s Theoretical Model for Evaluating the Quality of Medical Care guided the 
design and implementation of this study. Donabedian’s framework is the most commonly used 
theoretical framework for evaluating the quality of healthcare services (Ayanian and Markel, 
2016). According to Donabedian, three concepts (i.e., structure, process, and outcome) are the 
guiding principles for quality improvement. Donabedian’s model was appropriate for this study 
because the model is descriptive, explanatory, accurate, practical, simple, consistent, and acute in 
identifying links between practice processes and patient outcomes in the perioperative setting 
(Birkmeyer et al., 2004; Centurion et al., 2018; Hannan et al., 2001; Moore et al., 2015; Rose et 
al., 2019; Tsai et al., 2013).  
Review of the Methodology 
The study employed a non-experimental ex post facto secondary data analysis design. 
This design was used to retrospectively compare participants’ baseline P300 AEPs to MoCA 
scores before surgery and anesthesia and to evaluate for group differences in pre- to 
postoperative P300 AEP change scores between participants who received two or more PNMMA 
medications versus those who did not. This study’s research question was: Could P300 AEPs 
obtained using the WAVi MedicalTM system potentially enhance perioperative brain health 
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assessment and provide neurobiomarkers that aid in the development of perioperative brain 
health protection protocols for older surgical patients?  
Specific Aim #1: Evaluate the ability of participants’ preoperative baseline P300 latency 
(i.e., brain speed) and P300 amplitude (i.e., brain power) to predict participants’ cognitive 
function. This study used regression to understand whether auditory P300 amplitude (in 
microvolts) and auditory P300 latency (in milliseconds) predict cognitive function among 
older surgical patients as assessed by MoCA. Each variable was considered 
independently as they measure two separate constructs of neurocognition, namely 
cognitive resources (i.e., brain power) and cognitive efficiency (i.e., brain speed).  
Hypothesis #1: Lower P300 amplitude will be predictive of lower MoCA scores.  
Hypothesis #2: Higher P300 latency will be predictive of lower MoCA scores.  
Specific Aim #2: Evaluate for group differences in pre- to postoperative P300 AEP 
change scores (i.e., amplitude (in microvolts) and latency (in milliseconds)) between 
participants who received two or more potentially neuroprotective multimodal anesthetic 
adjunct medications (i.e., magnesium, lidocaine, and/or ketamine) versus those who did 
not.  
Hypothesis #3: Participants who received two or more potentially neuroprotective 
multimodal anesthetic agents will demonstrate a larger positive change in their 
P300 amplitude, measured as a pre- to postoperative change score in microvolts. 
Hypothesis #4: Participants who received two or more potentially neuroprotective 
multimodal anesthetic agents will demonstrate a smaller degree of prolongation in 
their P300 latency relative to their baseline, measured as a pre- to postoperative 
change score in milliseconds.   
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Regression was completed to evaluate data for study aim #1 to assess whether auditory 
P300 amplitude (in microvolts) and auditory P300 latency (in milliseconds) predicted 
participants’ MoCA scores. A pair of one-way ANOVA analyses were completed for study aim 
#2 to determine whether a difference existed in pre-and postoperative P300 amplitude (in 
microvolts) and P300 latency (in milliseconds) change scores between participants who received 
two or more PNMMA medications and those who did not. 
Synopsis of Major Findings 
For study aim one, regression was employed to evaluate whether auditory P300 
amplitude or latency were predictive of MoCA scores.  
H1: Lower P300 amplitude will be predictive of lower MoCA scores.  
The regression equation was not significant (F(1,13) = 0.021, p > 0.05) with an r2 of 0.002. P300 
amplitude was not a significant predictor of MoCA score in this sample. 
H2: Increased P300 latency will be predictive of lower MoCA scores.  
The regression equation was not significant (F(1,13) = 0.052, p > 0.05) with an r2 of 0.004. P300 
latency was not a significant predictor for MoCA score in this sample. 
For study aim two, ANOVA was employed to evaluate for group differences in pre- to 
postoperative P300 AEP change scores between participants who received two or more PNMMA 
medications and participants who did not.  
H3: Participants who received two or more potentially neuroprotective multimodal 
anesthetic agents will demonstrate a larger positive change in their P300 amplitude, 
measured as a pre- to postoperative change score in microvolts.  
The analysis identified a significant difference between the two groups (F(1,8) = 12.093, p < 
0.05). Post hoc analysis revealed that participants who received two or more PNMMA 
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medications demonstrated a larger positive postoperative change in their P300 amplitude (M = 
4.33, sd = 4.29, 95% CI = [-0.17, 8.83]) than participants who did not (M = -3.45, sd = 1.19, 95% 
CI = [-5.34, -1.56]). 
H4: Participants who received two or more potentially neuroprotective multimodal 
anesthetic agents will demonstrate a smaller degree of prolongation in their P300 latency 
relative to their baseline, measured as a pre- to postoperative change score in 
milliseconds.   
No significant difference was identified in participants’ P300 latency change scores between the 
two groups (F(1, 8) = 0.245, p > 0.05). Participants who received two or more PNMMA agents 
had a mean change score of 14.76 (sd = 76.01, 95% CI = [-65.10, 94.43]). Participants who did 
not receive two or more PNMMA agents had a mean change score of -9 (sd = 70.53, 95% CI = -
121.23, 103.23]). 
Findings Related to the Literature  
This study found no association between participants’ P300 AEPs and MoCA scores. 
However, the sample population for this study consisted of four participants that identified as 
African American (27%) and 11 that identified as Caucasian (73%). Rossetti et al. (2017) 
identified that several components of the MoCA and previously established cut-off points for 
cognitive impairment are not well suited for African Americans. In a sample of over 1,000 
community-dwelling African Americans with an average age of 49 years and no subjective 
cognitive complaints, the mean MoCA score was 22 (Rossetti et al., 2017). In this Rossetti et 
al.’s study, 72% of participants were unable to complete the cube drawing task, 66% of 
participants recalled fewer than 4/5 delayed free recall words, 63% were unable to complete the 
sentence repetition task, and 45% failed the abstraction portion of the assessment (Rossetti et al., 
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2017). These factors all present challenges for the use of MoCA as a routine clinical preoperative 
neurocognitive screening tool as MoCA may underestimate neurocognitive function in African 
American patients (i.e., MoCA scores may be lower for African Americans than for Caucasians 
with an equivalent level of cognitive function). Future research may consider evaluating the 
relationship between P300 AEPs and MoCA scores while controlling for the impact of potential 
ethnic and/or education biases on MoCA scores. It is also possible that MoCA provides different 
information regarding a patient’s baseline neurocognitive state and ultimate risk for 
postoperative neurocognitive changes (e.g., POD) than do P300 AEPs.  
This study also evaluated group differences in pre- to postoperative P300 AEP change 
scores between participants who received two or more PNMMA medications and participants 
who did not. Lidocaine, ketamine, and magnesium are each reported to potentially reduce the 
risk of postoperative cognitive impairment (Bhudia et al., 2007; Mack et al., 2009; Chen et al., 
2015; and Hovaguimian et al., 2018). Of particular interest, is the possible synergistic effect of 
these potentially neuroprotective anesthetic adjunct medications. Mendonca et al. (2020) 
reported a positive synergistic effect using a combination of lidocaine and magnesium for 
perioperative pain management. Fang et al. (2020) reported that combining lidocaine with 
ketamine “may be beneficial in shortening the onset of anesthesia, promoting postoperative 
awaking…and [reducing the] incidence of adverse reactions” compared to administering 
ketamine alone (p. 1). It is possible that similar synergistic neuroprotective effects exist when 
combining two or more PNMMA for older surgical patients.  
While the hypothesized differences in amplitude were supported (H3), the differences in 
latency (H4) were not. This finding eludes to, but does not confirm, the possibility that a 
synergistic neuroprotective effect could exist in older surgical patients receiving these 
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medications. Of interest, the impact of sub-anesthetic doses of ketamine administered as a sole 
agent have been previously determined to reduce auditory evoked P300 amplitude without an 
impact on latency (Schwertner, et al., 2018). However, no studies that evaluated the impact of 
ketamine, lidocaine, and/or magnesium on pre- to postoperative P300 AEP change scores in the 
perioperative setting were identified in the literature. Future studies with larger sample sizes, 
higher statistical power, and the inclusion of covariate analysis are needed to investigate the 
potential neuroprotective effects of these medications and the potential utility of P300 AEPs as 
perioperative neurophysiologic biomarkers for trending cognitive function in the clinical setting.  
Limitations 
This study has limitations related to design, variable measures, and statistical analysis. 
These limitations may impact study findings and pose threats to the validity of study results. 
Study limitations are presented and discussed in this section.   
Selection bias poses a threat to the internal validity of this study. Selection bias results 
from preexisting between-group differences when study participants are not randomized into 
groups (Polit and Beck, 2017). Preexisting group differences (i.e., potential covariate factors), 
other than the independent variable(s) may have confounding influence on the dependent 
variable(s) (Polit and Beck, 2017). In the absence of covariate analysis, internal validity is 
threatened (Polit and Beck, 2017). 
For study aim 2, participants were assigned to one of two groups based on whether or not 
the participants received PNMMA medications as displayed by Table 12 in chapter five. One 
notable difference between these two groups was gender. In group one, 50% were male and 50% 
were female. In group two, 75% were male, and 25% were female. Based on the limited number 
of studies available, P300 amplitude may be impacted by gender (Melynyte et al., 2018). In a 
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recent systematic review, 50% of the studies reviewed by the authors demonstrated a higher 
amplitude on average for females versus males, purportedly resulting from anatomical and 
hormonal differences (Melynyte et al., 2018). The authors recommend that gender be considered 
as a potential covariate and note that additional studies and meta-analysis are needed to better 
determine the strength of association between P300 AEPs and gender (Melynyte et al., 2018).  
If a significant gender-associated difference does exist and is not controlled for as a 
covariate in future studies, an identified between-groups difference in those who receive an 
intervention (e.g., neuroprotective medication) and those who do not could be misinterpreted. 
Due to the small, fixed sample size available for this retrospective exploratory secondary data 
analysis, covariates were not incorporated into the analysis. Additional covariates that may be 
considered in future studies include: age, length of anesthesia, pain, and the participants’ 
emotional state at the time of assessment. Future studies with larger sample sizes will benefit 
from evaluating covariates to improve internal validity.   
Instrumentation effect poses a threat to the internal validity of this study. Instrumentation 
effect refers to a change in the assessment tool or methodology between two data collection 
points (Polit and Beck, 2017). Even if the same instrument is used for repeated assessments, 
instrumentation effect can bias study results if an assessment tool were more/less accurate on a 
follow-up assessment relative to the initial assessment (Polit and Beck, 2017). As previously 
mentioned, the principal assumption for this study was that the WAVi MedicalTM system 
provides valid and reliable assessment of P300 AEPs as the device was not independently 
validated by the data source study’s research team. This assumption was considered reasonable 
given the reported: 1) utility of P300 AEPs as a neurocognitive assessment metric (Sur & Sinha, 
2009; Parra et al., 2012; Yener, 2013, van Dinteren 2014; Grover et al., 2017; Clayton et al. 
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2020), 2) success using the WAVi MedicalTM system for conducting P300 AEPs in at least two 
recent publications (Grover et al., 2017; Clayton et al., 2020), and 3) ongoing neurocognition 
clinical studies employing the WAVi MedicalTM system (National Institutes of Health, 2018; 
Clinicaltrials.gov, 2018). However, without independent validation of the instrument or 
documented validation studies in the literature, one cannot be absolutely certain of a device’s 
test-retest reliability. Prior to future studies, independent validation of the test-retest reliability of 
the WAVi MedicalTM system would reduce the potential for instrumentation effect and 
strengthen the internal validity of future studies utilizing this device.  
Low statistical power poses a threat to the statistical conclusion validity of this study. At 
best, regression-based analyses are used to identify relationships between variables (Tabachnick 
and Fidell, 2013). As previously noted, no relationship was identified between preoperative P300 
amplitude and MoCA scores (H1) nor between preoperative P300 latency and MoCA scores (H2). 
Hypothesized differences in pre- to postoperative amplitude change scores were supported (H3), 
but the hypothesized differences in pre- to postoperative latency change scores (H4) were not. 
However, the statistical conclusion validity of these results is threatened by a lack of statistical 
power given the data source study’s relatively small sample size. Future studies will benefit from 
an increase in sample size to increase statistical power and reduce the threat to statistical 
conclusion validity.  
Novelty effect poses a threat to the construct validity of this study. Novelty effect 
references the potential impact that a study participant’s skepticism or enthusiasm about 
participating in a new assessment technique can have on the results of initial assessment relative 
to follow-up assessment (Polit and Beck, 2017). For example, during the data source study, a 
participant may have been either more skeptical or enthusiastic when participating in 
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preoperative neurocognitive assessments than they were when participating in postoperative 
assessments as a result of novelty effect. Future studies may consider familiarizing study 
participants with the study’s planned neurocognitive assessment techniques prior to the baseline 
preoperative assessment in order to mitigate potential influence of novelty effects on study 
outcomes to enhance conclusion validity.  
The study’s sample poses a threat the external validity of this study. External validity 
refers to the generalizability of the sample population’s results to the target population (Polit and 
Beck, 2017). As previously mentioned, the data source study’s sample population was a 
convenience sample of older surgical patients presenting to the PACE clinic at a single academic 
medical center. The sample is reasonably diverse given the relatively small number of 
participants available from the data source study including: male and female gender, two ethnic 
groups, ages ranging from 66-82, and four different surgical services. However, this sample is 
not ideally representative of the diversity among the target population (i.e., older surgical 
patients throughout the U.S.). Future studies could consider utilizing a combination of quota 
sampling and stratified randomization to obtain a sample population that better represents the 
target population to enhance external validity (i.e., generalizability of the study’s results).  
Conclusions and Recommendations for Future Research  
This study evaluated potential relationships between P300 AEPs and MoCA scores and 
differences in pre- to postoperative P300 AEP change scores between participants who received 
two or more PNMMA adjunct medications versus those who did not. The ultimate goal of this 
study was to contribute to the state of the science in search of a perioperative neurocognitive 
assessment that is rapid, easily-administrable, valid, reliable, automatically scored, void of 
language, cultural, and education bias and cost-efficient (Axley & Schenning, 2015). Such an 
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assessment is needed as the brain, anesthesia’s primary target, is limitedly assessed within the 
perioperative setting, perioperative cognitive morbidity among older surgical patients is common 
and costly, and perioperative brain health is a public health and research priority (American 
Society of Anesthesiologists, 2019).  
In this study’s sample, an association between participants’ P300 AEPs and MoCA 
scores was not identified. However, Berger et al. (2018) reported that there is insufficient data to 
report sensitivity and specificity for MoCA in the perioperative setting and that MoCA has an 
inherent education bias. Rossetti et al. (2017) identified that several components of the MoCA 
and previously established cut-off points for cognitive impairment are not well suited for African 
Americans. P300 AEP derived neurobiomarkers may also assess a different aspect of brain 
health and provide alternative information related to a patient’s preoperative risk of POD versus 
the MoCA assessment.  
A statistically significant difference in P300 amplitude change scores between 
participants who received two or more PNMMA medications versus those who did not was 
identified. Participants who received two or more PNMMA medications demonstrated a larger 
positive postoperative change in their P300 amplitude than participants who did not. This finding 
may point to, but does not confirm, the possibility that a synergistic neuroprotective effect could 
exist in older surgical patients receiving these medications. Future investigations with larger 
samples sizes and higher statistical power are needed to further explore these effects.  
This study found no significant difference in participants’ P300 latency change scores 
between participants who received two or more PNMMA medications versus those who did not. 
This finding may call attention to the potential for P300 signal amplitude to serve as a 
perioperative neurophysiologic biomarker for trending cognitive function versus P300 latency. 
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However, this finding may also be the result of an underpowered study. In future studies, 
investigators may consider controlling for confounding perioperative factors that potentially 
impact P300 auditory evoked potentials (e.g., gender, age, length of anesthesia, pain, and 
emotional state at the time of assessment) as the clinical utility of these potential biomarkers is 
refined. 
Pending further investigation, EEG-based neurobiomarkers may assist the development 
of perioperative brain health protection protocols that reduce the incidence and/or severity of 
perioperative neurocognitive disorders in older surgical patients. First, future research may 
consider evaluating the relationship between P300 AEPs and MoCA scores while controlling for 
the impact of potential ethnic and/or education biases on MoCA scores. Second, investigators 
may consider evaluating P300 amplitude as a perioperative neurocognitive trend metric while 
controlling for potentially confounding perioperative factors. Future research may also consider 
the potential utility of alternative EEG-based neurobiomarkers such as peak alpha frequencies or 
theta/beta ratios. Future studies will benefit from an increase in sample size and resulting 
increase in statistical power. 
Investigation in search of a perioperative neurocognitive assessment that is rapid, easily-
administrable, valid, reliable, automatically scored, void of language, cultural, and education bias 
and cost-efficient needs to be continued. The brain, anesthesia’s primary target, is currently 
poorly assessed within the perioperative setting. Perioperative cognitive morbidity among older 
surgical patients remains an all too common and costly phenomenon needing to be addressed. 
Until a perioperative cognitive screening tool capable of 1) predicting POD risk and stratifying 
patients into risk categories, 2) detecting mild cognitive impairments currently missed by brief 
cognitive screening tools (e.g., MoCA, Mini-Cog©, and CAM), and 3) objectively tracking the 
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progression of postoperative cognitive changes over time, reducing the incidence and severity of 
POD will likely remain a problematic public health and research priority with few clearly 
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